{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:37:11Z","timestamp":1791909431644,"version":"4.3.4"},"reference-count":345,"publisher":"Bentham Science Publishers Ltd.","issue":"29","funder":[{"DOI":"10.13039\/501100006206","name":"Agency of the Czech University of Life Sciences Prague","doi-asserted-by":"publisher","award":["CIGA 20175001"],"award-info":[{"award-number":["CIGA 20175001"]}],"id":[{"id":"10.13039\/501100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006206","name":"Internal Grant Agency of the Faculty of Tropical AgriSciences","doi-asserted-by":"publisher","award":["IGA 20175020"],"award-info":[{"award-number":["IGA 20175020"]}],"id":[{"id":"10.13039\/501100006206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,10,26]]},"abstract":"<jats:sec>\n                    <jats:title>:<\/jats:title>\n                    <jats:p>A number of papers reporting antimicrobial properties of extracts, essential oils, resins and various classes of compounds isolated from higher plants have been published in recent years; however, a comprehensive analysis of plant-derived antimicrobial agents currently applied in practice for the improvement of human health is still lacking. This review summarizes data on clinical efficacy, antimicrobial effects and the chemistry of commercially available antibacterial and antifungal agents of plant origin currently used in the prevention and treatment of gastrointestinal, oral, respiratory, skin, and urinary infections. As a result of an analysis of the literature, more than 40 plant-derived over-the-counter pharmaceuticals, dietary supplements, cosmetics, herbal medicines, and functional foods containing complex mixtures (e.g. Glycyrrhiza glabra extract, Melaleuca alternifolia essential oil, and Pistacia lentiscus resin), pure compounds (e.g. benzoic acid, berberine, eucalyptol, salicylic acid and thymol) as well as their derivatives and complexes (e.g. bismuth subsalicylate and zinc pyrithione) have been identified. The effectiveness of many of these products is illustrated by results of clinical trials and supported by data on there in vitro antimicrobial activity. A broad spectrum of various commercial products currently available on the market and their welldocumented clinical efficacy suggests that plants are prospective sources for the identification of new types of antimicrobial agents in future. Innovative approaches and methodologies for effective proof-of-concept research and the development of new types of plant-derived products effective against recently emerging problems related to human microbial diseases (e.g. antimicrobial resistance) are also proposed in this review.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867325666180831144344","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:45:47Z","timestamp":1536626747000},"page":"5501-5541","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["Plant-Derived Products as Antibacterial and Antifungal Agents in Human Health Care"],"prefix":"10.2174","volume":"26","author":[{"given":"Ladislav","family":"Kokoska","sequence":"first","affiliation":[{"name":"Department of Crop Sciences and Agroforestry, Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague, Kamycka 129, Prague - Suchdol, 165 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kloucek","sequence":"additional","affiliation":[{"name":"Department of Quality of Agricultural Products, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, Prague - Suchdol, 165 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Leuner","sequence":"additional","affiliation":[{"name":"Department of Crop Sciences and Agroforestry, Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague, Kamycka 129, Prague - Suchdol, 165 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Novy","sequence":"additional","affiliation":[{"name":"Department of Quality of Agricultural Products, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, Prague - Suchdol, 165 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/nbt1206-1504","volume":"24","author":"Lewis K.","year":"2006","unstructured":"Lewis K.; Ausubel F.M.; Prospects for plant-derived antibacterials. Nat Biotechnol 2006,24(12),1504-1507","journal-title":"Nat Biotechnol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.anbehav.2005.03.005","volume":"70","author":"Hart B.L.","year":"2005","unstructured":"Hart B.L.; The evolution of herbal medicine: behavioural perspectives. Anim Behav 2005,70(5),975-989","journal-title":"Anim Behav"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2005.07.008","volume":"27","author":"Gurib-Fakim A.","year":"2006","unstructured":"Gurib-Fakim A.; Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006,27(1),1-93","journal-title":"Mol Aspects Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"White N.J.","year":"2008","unstructured":"White N.J.; Qinghaosu (artemisinin): the price of success. Science 2008,320(5874),330-334","journal-title":"Science"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jep.2011.04.051","volume":"136","author":"Wang G-W.","year":"2011","unstructured":"Wang G-W.; Hu W-T.; Huang B-K.; Qin L-P.; Illicium verum: a review on its botany, traditional use, chemistry and pharmacology. J Ethnopharmacol 2011,136(1),10-20","journal-title":"J Ethnopharmacol"},{"key":"ref=6","unstructured":"The Nobel Prize in Physiology or Medicine. Nobelprize. org.: Nobel Media AB 2014. Available at: ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.nobelprize.org\/nobel_prizes\/medicine\/laureates\/2015\/\">http:\/\/www.nobelprize.org\/nobel_prizes\/medicine\/laureates\/2015\/ Accessed: December 4, 2017]."},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/CMR.12.4.564","volume":"12","author":"Cowan M.M.","year":"1999","unstructured":"Cowan M.M.; Plant products as antimicrobial agents. Clin Microbiol Rev 1999,12(4),564-582","journal-title":"Clin Microbiol Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2174\/0929867033457719","volume":"10","author":"Kalemba D.","year":"2003","unstructured":"Kalemba D.; Kunicka A.; Antibacterial and antifungal properties of essential oils. Curr Med Chem 2003,10(10),813-829","journal-title":"Curr Med Chem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568012033483079","volume":"2","author":"Khafagi I.","year":"2003","unstructured":"Khafagi I.; Dewedar A.; Amein M.; Opportunities of finding novel anti-infective agents from plant cell cultures. Curr Med Chem Antiinfect Agents 2003,2(3),191-211","journal-title":"Curr Med Chem Antiinfect Agents"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2174\/0929867043365107","volume":"11","author":"Lai P.K.","year":"2004","unstructured":"Lai P.K.; Roy J.; Antimicrobial and chemopreventive properties of herbs and spices. Curr Med Chem 2004,11(11),1451-1460","journal-title":"Curr Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijantimicag.2005.09.002","volume":"26","author":"Cushnie T.P.","year":"2005","unstructured":"Cushnie T.P.; Lamb A.J.; Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005,26(5),343-356","journal-title":"Int J Antimicrob Agents"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.2174\/1381612054367481","volume":"11","author":"Mahady G.B.","year":"2005","unstructured":"Mahady G.B.; Medicinal plants for the prevention and treatment of bacterial infections. Curr Pharm Des 2005,11(19),2405-2427","journal-title":"Curr Pharm Des"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jep.2005.04.025","volume":"100","author":"R\u00edos J.L.","year":"2005","unstructured":"R\u00edos J.L.; Recio M.C.; Medicinal plants and antimicrobial activity. J Ethnopharmacol 2005,100(1-2),80-84","journal-title":"J Ethnopharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1590\/S1678-91992010000300006","volume":"16","author":"Silva N.C.C.","year":"2010","unstructured":"Silva N.C.C.; Fernandes A.; Junior Biological properties of medicinal plants: A review of their antimicrobial activity. J Venom Anim Toxins Trop Dis 2010,16(3),402-413","journal-title":"J Venom Anim Toxins Trop Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2174\/138161211795703807","volume":"17","author":"Termentzi A.","year":"2011","unstructured":"Termentzi A.; Fokialakis N.; Skaltsounis A.L.; Natural resins and bioactive natural products thereof as potential antimicrobial agents. Curr Pharm Des 2011,17(13),1267-1290","journal-title":"Curr Pharm Des"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1039\/c2np20035j","volume":"29","author":"Abreu A.C.","year":"2012","unstructured":"Abreu A.C.; McBain A.J.; Sim\u00f5es M.; Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep 2012,29(9),1007-1021","journal-title":"Nat Prod Rep"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3012462","volume":"2016","author":"Swamy M.K.","year":"2016","unstructured":"Swamy M.K.; Akhtar M.S.; Sinniah U.R.; Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evid Based Complement Alternat Med 2016,2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.micres.2016.12.003","volume":"196","author":"Barbieri R.","year":"2017","unstructured":"Barbieri R.; Coppo E.; Marchese A.; Daglia M.; Sobarzo-S\u00e1nchez E.; Nabavi S.F.; Nabavi S.M.; Phytochemicals for human disease: an update on plant-derived compounds antibacterial activity. Microbiol Res 2017,196,44-68","journal-title":"Microbiol Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jep.2006.04.003","volume":"106","author":"Cos P.","year":"2006","unstructured":"Cos P.; Vlietinck A.J.; Berghe D.V.; Maes L.; Anti-infective potential of natural products: how to develop a stronger in vitro \u2018proof-of-concept\u2019. J Ethnopharmacol 2006,106(3),290-302","journal-title":"J Ethnopharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1055\/s-2008-1074518","volume":"74","author":"Gibbons S.","year":"2008","unstructured":"Gibbons S.; Phytochemicals for bacterial resistance--strengths, weaknesses and opportunities. Planta Med 2008,74(6),594-602","journal-title":"Planta Med"},{"key":"ref=21","first-page":"104","volume":"4","author":"Das K.","year":"2010","unstructured":"Das K.; Tiwari R.K.S.; Shrivastava D.K.; Techniques for evaluation of medicinal plant products as antimicrobial agent: Current methods and future trends. J Med Plants Res 2010,4(2),104-111","journal-title":"J Med Plants Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2217\/fmb.12.68","volume":"7","author":"Savoia D.","year":"2012","unstructured":"Savoia D.; Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiol 2012,7(8),979-990","journal-title":"Future Microbiol"},{"key":"ref=23","unstructured":"World Health Organization. Available at: ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.who.int\/en\/\">http:\/\/www.who.int\/en\/ [Accessed: May 23, 2017]"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/gut.2003.022103","volume":"53","author":"Casburn-Jones A.C.","year":"2004","unstructured":"Casburn-Jones A.C.; Farthing M.J.G.; Management of infectious diarrhoea. Gut 2004,53(2),296-305","journal-title":"Gut"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/jac\/dkv155","volume":"70","author":"L\u00f3pez-G\u00f3ngora S.","year":"2015","unstructured":"L\u00f3pez-G\u00f3ngora S.; Puig I.; Calvet X.; Villoria A.; Baylina M.; Mu\u00f1oz N.; Sanchez-Delgado J.; Suarez D.; Garc\u00eda-Hernando V.; Gisbert J.P.; Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection. J Antimicrob Chemother 2015,70(9),2447-2455","journal-title":"J Antimicrob Chemother"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"Malfertheiner P.","year":"2012","unstructured":"Malfertheiner P.; Megraud F.; OMorain, C.A.; Atherton, J.; Axon, A.T.; Bazzoli, F.; Gensini, G.F.; Gisbert, J.P.; Graham, D.Y.; Rokkas, T.; El-Omar, E.M.; Kuipers, E.J. Management of Helicobacter pylori infection-the Maastricht IV\/Florence Consensus Report. Gut 2012,61(5),646-664","journal-title":"Gut"},{"key":"ref=27","author":"Bruneton J.","year":"1999","unstructured":"Bruneton J.; Pharmacognosy: Phytochemistry, Medicinal Plants 1999","journal-title":"Pharmacognosy: Phytochemistry, Medicinal Plants"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/BF02803833","volume":"37","author":"Chauhan R.K.S.","year":"1970","unstructured":"Chauhan R.K.S.; Jain A.M.; Bhandari B.; Berberine in the treatment of childhood diarrhoea. Indian J Pediatr 1970,37(274),577-579","journal-title":"Indian J Pediatr"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/BF02749333","volume":"36","author":"Chauhan R.K.S.","year":"1969","unstructured":"Chauhan R.K.S.; Jain A.M.; Dube M.K.; Bhandari B.; A combination of sulfadimidine, neomycin and berberine in the treatment of infectious diarrhoea. Indian J Pediatr 1969,36(258),242-244","journal-title":"Indian J Pediatr"},{"key":"ref=30","first-page":"22","volume":"54","author":"Sharda D.C.","year":"1970","unstructured":"Sharda D.C.; Berberine in the treatment of diarrhoea of infancy and childhood. J Indian Med Assoc 1970,54(1),22-24","journal-title":"J Indian Med Assoc"},{"key":"ref=31","first-page":"496","volume":"7","author":"Sharma R.","year":"1970","unstructured":"Sharma R.; Joshi C.K.; Goyal R.K.; Berberine tannate in acute diarrhoea. Indian Pediatr 1970,7(9),496-501","journal-title":"Indian Pediatr"},{"key":"ref=32","first-page":"462","volume":"8","author":"Desai A.B.","year":"1971","unstructured":"Desai A.B.; Shah K.M.; Shah D.M.; Berberine in treatment of diarrhoea. Indian Pediatr 1971,8(9),462-465","journal-title":"Indian Pediatr"},{"key":"ref=33","first-page":"88","volume":"21","author":"Naruka B.S.","year":"1979","unstructured":"Naruka B.S.; Sharma U.; Saxena S.; Sharma M.L.; Berberine in the treatment of infective diarrhea of infancy and childhood. Arch Child Health 1979,21(4),88-98","journal-title":"Arch Child Health"},{"key":"ref=34","first-page":"1","volume":"48","author":"Lahiri S.C.","year":"1967","unstructured":"Lahiri S.C.; Dutta N.K.; Berberine and chloramphenicol in the treatment of cholera and severe diarrhoea. J Indian Med Assoc 1967,48(1),1-11","journal-title":"J Indian Med Assoc"},{"key":"ref=35","first-page":"93","volume":"27","author":"Singh D.","year":"1974","unstructured":"Singh D.; Hussain R.; Clinical trials with berberine hydrochloride in the control of acute diarrhoeas. Indian Pract 1974,27(2),93-100","journal-title":"Indian Pract"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/bmj.291.6509.1601","volume":"291","year":"1985","unstructured":"Myo-Khin; Nyunt-Nyunt-Wai; Aye-Kyaw; Tin-U, Clinical trial of berberine in acute watery diarrhoea. Br Med J (Clin Res Ed) Khin-Maung-U.1985,291(6509),1601-1605","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/ptr.5475","volume":"29","author":"Chen C.","year":"2015","unstructured":"Chen C.; Tao C.; Liu Z.; Lu M.; Pan Q.; Zheng L.; Li Q.; Song Z.; Fichna J.; A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res 2015,29(11),1822-1827","journal-title":"Phytother Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/infdis\/155.5.979","volume":"155","author":"Rabbani G.H.","year":"1987","unstructured":"Rabbani G.H.; Butler T.; Knight J.; Sanyal S.C.; Alam K.; Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 1987,155(5),979-984","journal-title":"J Infect Dis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10096-014-2132-9","volume":"33","author":"Zhou F.F.","year":"2014","unstructured":"Zhou F.F.; Wu S.; Klena J.D.; Huang H.H.; Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China. Eur J Clin Microbiol Infect Dis 2014,33(10),1773-1779","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/AAC.32.8.1274","volume":"32","author":"Sun D.","year":"1988","unstructured":"Sun D.; Abraham S.N.; Beachey E.H.; Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli. Antimicrob Agents Chemother 1988,32(8),1274-1277","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/IAI.35.2.471-475.1982","volume":"35","author":"Sack R.B.","year":"1982","unstructured":"Sack R.B.; Froehlich J.L.; Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 1982,35(2),471-475","journal-title":"Infect Immun"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1254\/fpj.101.3_169","volume":"101","author":"Yamamoto K.","year":"1993","unstructured":"Yamamoto K.; Takase H.; Abe K.; Saito Y.; Suzuki A.; Pharmacological studies on antidiarrheal effects of a preparation containing berberine and geranii herba Nippon Yakurigaku Zasshi 1993,101(3),169-175","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"ref=43","first-page":"116","volume":"310","author":"Tsai C.S.","year":"1991","unstructured":"Tsai C.S.; Ochillo R.F.; Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Arch Int Pharmacodyn Ther 1991,310,116-131","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.fitote.2012.05.015","volume":"83","author":"Zhang Y.","year":"2012","unstructured":"Zhang Y.; Wang X.; Sha S.; Liang S.; Zhao L.; Liu L.; Chai N.; Wang H.; Wu K.; Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model. Fitoterapia 2012,83(6),1014-1022","journal-title":"Fitoterapia"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1139\/m69-190","volume":"15","author":"Amin A.H.","year":"1969","unstructured":"Amin A.H.; Subbaiah T.V.; Abbasi K.M.; Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol 1969,15(9),1067-1076","journal-title":"Can J Microbiol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF02818693","volume":"47","author":"Cern\u00e1kov\u00e1 M.","year":"2002","unstructured":"Cern\u00e1kov\u00e1 M.; Kost\u00e1lov\u00e1 D.; Antimicrobial activity of berberine--a constituent of Mahonia aquifolium. Folia Microbiol (Praha) 2002,47(4),375-378","journal-title":"Folia Microbiol (Praha)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4172\/2161-069X.1000110","volume":"2","author":"Allegrini A.","year":"2012","unstructured":"Allegrini A.; Costantini M.; Gelatine tannate for the treatment of acute diarrhoea in adults. J Gastrointest Dig Syst 2012,2(3),110","journal-title":"J Gastrointest Dig Syst"},{"key":"ref=48","year":"1992","unstructured":"FAO Food Nutr Pap Compendium of Food Additive Apecifications. Addendum 1. Joint FAO\/WHO Expert Committee on Food Additives52(1-141), 118-121.1992","journal-title":"FAO Food Nutr Pap"},{"key":"ref=49","first-page":"186","volume":"6","author":"Salama-Muller A.","year":"2010","unstructured":"Salama-Muller A.; Muller B.; Dume U.; Treatment of acute diarrhea with Tannacomp - Results of a post marketing surveillance study in an outpatient setting. Med Welt 2010,6(1),186-190","journal-title":"Med Welt"},{"key":"ref=50","first-page":"499","volume":"10","author":"Schlicker G.","year":"1997","unstructured":"Schlicker G.; Lerbs W.; Therapy of acute diarrhea in childhood. Intermediate evaluation of an observation study with Tannalbin capsules. TW Padiatrie 1997,10(9),499-502","journal-title":"TW Padiatrie"},{"key":"ref=51","first-page":"1178","volume":"45","author":"Hoppe K.","year":"1995","unstructured":"Hoppe K.; Treatment of unspecific diarrhea with broad pharmacological drug combinations. Therapiewoche 1995,45(20),1178-1181","journal-title":"Therapiewoche"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/BF01649558","volume":"69","author":"Raedsch R.","year":"1991","unstructured":"Raedsch R.; Walter-Sack I.; Galle P.R.; Kommerell B.; Prophylaxis of traveler\u2019s diarrhea in Egypt: results of a double blind controlled study. Klin Wochenschr 1991,69(19),863-866","journal-title":"Klin Wochenschr"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010530","volume":"6","author":"Micha\u0142ek D.","year":"2016","unstructured":"Micha\u0142ek D.; Ko\u0142odziej M.; Konarska Z.; Szajewska H.; Efficacy and safety of gelatine tannate for the treatment of acute gastroenteritis in children: protocol of a randomised controlled trial. BMJ Open 2016,6(2)","journal-title":"BMJ Open"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4321\/S1130-01082009000100005","volume":"101","author":"Esteban Carretero J.","year":"2009","unstructured":"Esteban Carretero J.; Durban Reguera F.; Lopez-Argueta Alvarez S.; Lopez Montes J.; A comparative analysis of response to ORS (oral rehydration solution) vs. ORS + gelatin tannate in two cohorts of pediatric patients with acute diarrhea. Rev Esp Enferm Dig 2009,101(1),41-48","journal-title":"Rev Esp Enferm Dig"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1016\/0031-9422(91)83426-L","volume":"30","author":"Scalbert A.","year":"1991","unstructured":"Scalbert A.; Antimicrobial properties of tannins. Phytochemistry 1991,30(12),3875-3883","journal-title":"Phytochemistry"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/10408699891274273","volume":"38","author":"Chung K.T.","year":"1998","unstructured":"Chung K.T.; Wong T.Y.; Wei C.I.; Huang Y.W.; Lin Y.; Tannins and human health: a review. Crit Rev Food Sci Nutr 1998,38(6),421-464","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1472-765X.1993.tb01428.x","volume":"17","author":"Chung K.T.","year":"1993","unstructured":"Chung K.T.; Stevens S.E.; Lin W.F.; Wei C.I.; Growth inhibition of selected food-borne bacteria by tannic acid, propyl gallate and related compounds. Lett Appl Microbiol 1993,17(1),29-32","journal-title":"Lett Appl Microbiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.foodchem.2009.05.060","volume":"118","author":"Kim T.J.","year":"2010","unstructured":"Kim T.J.; Silva J.L.; Kim M.K.; Jung Y.S.; Enhanced antioxidant capacity and antimicrobial activity of tannic acid by thermal processing. Food Chem 2010,118(3),740-746","journal-title":"Food Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1744-7348.2002.tb00176.x","volume":"140","author":"Pierpoint W.S.","year":"2002","unstructured":"Pierpoint W.S.; Can aspirin help identify leaf proteins active in defence responses? Ann Appl Biol 2002,140(3),233-239","journal-title":"Ann Appl Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/clinids\/12.Supplement_1.S3","volume":"12","author":"Bierer D.W.","year":"1990","unstructured":"Bierer D.W.; Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis 1990,12(Suppl. 1),S3-S8","journal-title":"Rev Infect Dis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ddr.21086","volume":"74","author":"Damman C.J.","year":"2013","unstructured":"Damman C.J.; Salicylates and the microbiota: A new mechanistic understanding of an ancient drug\u2019s role in dermatological and gastrointestinal disease. Drug Dev Res 2013,74(6),344-352","journal-title":"Drug Dev Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/infdis\/157.5.1008","volume":"157","author":"Steffen R.","year":"1988","unstructured":"Steffen R.; Mathewson J.J.; Ericsson C.D.; DuPont H.L.; Helminger A.; Balm T.K.; Wolff K.; Witassek F.; Travelers\u2019 diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy. J Infect Dis 1988,157(5),1008-1013","journal-title":"J Infect Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"15S","DOI":"10.1016\/0002-9343(90)90270-N","volume":"88","author":"DuPont H.L.","year":"1990","unstructured":"DuPont H.L.; Flores Sanchez J.; Ericsson C.D.; Mendiola Gomez J.; DuPont M.W.; Cruz Luna A.; Mathewson J.J.; Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea. Am J Med 1990,88(6A),15S-19S","journal-title":"Am J Med"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1542\/peds.87.1.18","volume":"87","author":"Soriano-Br\u00fccher H.","year":"1991","unstructured":"Soriano-Br\u00fccher H.; Avenda\u00f1o P.; O\u2019Ryan M.; Braun S.D.; Manhart M.D.; Balm T.K.; Soriano H.A.; Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study. Pediatrics 1991,87(1),18-27","journal-title":"Pediatrics"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJM199306103282301","volume":"328","author":"Figueroa-Quintanilla D.","year":"1993","unstructured":"Figueroa-Quintanilla D.; Salazar-Lindo E.; Sack R.B.; Le\u00f3n-Bar\u00faa R.; Sarabia-Arce S.; Campos-S\u00e1nchez M.; Eyzaguirre-Maccan E.; A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med 1993,328(23),1653-1658","journal-title":"N Engl J Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/080352501750258630","volume":"90","author":"Chowdhury H.R.","year":"2001","unstructured":"Chowdhury H.R.; Yunus M.; Zaman K.; Rahman A.; Faruque S.M.; Lescano A.G.; Sack R.B.; The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. Acta Paediatr 2001,90(6),605-610","journal-title":"Acta Paediatr"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/00365529208999958","volume":"27","author":"Westblom T.U.","year":"1992","unstructured":"Westblom T.U.; Madan E.; Subik M.A.; Duriex D.E.; Midkiff B.R.; Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection. Scand J Gastroenterol 1992,27(3),249-252","journal-title":"Scand J Gastroenterol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1007\/BF01303177","volume":"38","author":"Marshall B.J.","year":"1993","unstructured":"Marshall B.J.; Valenzuela J.E.; McCallum R.W.; Dooley C.P.; Guerrant R.L.; Cohen H.; Frierson H.F.; Field L.G.; Jerdack G.R.; Mitra S.; Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial. Dig Dis Sci 1993,38(9),1674-1680","journal-title":"Dig Dis Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/19490976.2015.1008336","volume":"6","author":"Pitz A.M.","year":"2015","unstructured":"Pitz A.M.; Park G.W.; Lee D.; Boissy Y.L.; Vinj\u00e9 J.; Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens. Gut Microbes 2015,6(2),93-100","journal-title":"Gut Microbes"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/mdr.2013.0086","volume":"20","author":"Yakoob J.","year":"2014","unstructured":"Yakoob J.; Abbas Z.; Usman M.W.; Awan S.; Naz S.; Jafri F.; Hamid S.; Jafri W.; Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. Microb Drug Resist 2014,20(4),305-309","journal-title":"Microb Drug Resist"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/pathogens3020473","volume":"3","author":"Monte J.","year":"2014","unstructured":"Monte J.; Abreu A.C.; Borges A.; Sim\u00f5es L.C.; Sim\u00f5es M.; Antimicrobial activity of selected phytochemicals against Escherichia coli and Staphylococcus aureus and their biofilms. Pathogens 2014,3(2),473-498","journal-title":"Pathogens"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/j.1440-1746.2006.04194.x","volume":"21","author":"Shirin H.","year":"2006","unstructured":"Shirin H.; Moss S.F.; Kancherla S.; Kancherla K.; Holt P.R.; Weinstein I.B.; Sordillo E.M.; Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori. J Gastroenterol Hepatol 2006,21(9),1388-1393","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1440-1681.1984.tb00864.x","volume":"11","author":"Al-Habbal M.J.","year":"1984","unstructured":"Al-Habbal M.J.; Al-Habbal Z.; Huwez F.U.; A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin Exp Pharmacol Physiol 1984,11(5),541-544","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF02774571","volume":"21","author":"Huwez F.U.","year":"1986","unstructured":"Huwez F.U.; Al-Habbal M.J.; Mastic in treatment of benign gastric ulcers. Gastroenterol Jpn 1986,21(3),273-274","journal-title":"Gastroenterol Jpn"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.phymed.2009.09.010","volume":"17","author":"Dabos K.J.","year":"2010","unstructured":"Dabos K.J.; Sfika E.; Vlatta L.J.; Giannikopoulos G.; The effect of mastic gum on Helicobacter pylori: a randomized pilot study. Phytomedicine 2010,17(3-4),296-299","journal-title":"Phytomedicine"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/jac\/dkg366","volume":"52","author":"Bebb J.R.","year":"2003","unstructured":"Bebb J.R.; Bailey-Flitter N.; Ala\u2019Aldeen D.; Atherton J.C.; Mastic gum has no effect on Helicobacter pylori load in vivo. J Antimicrob Chemother 2003,52(3),522-523","journal-title":"J Antimicrob Chemother"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MEG.0b013e32831c50c9","volume":"21","author":"Kottakis F.","year":"2009","unstructured":"Kottakis F.; Kouzi-Koliakou K.; Pendas S.; Kountouras J.; Choli-Papadopoulou T.; Effects of mastic gum Pistacia lentiscus var. Chia on innate cellular immune effectors. Eur J Gastroenterol Hepatol 2009,21(2),143-149","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJM199812243392618","volume":"339","author":"Huwez F.U.","year":"1998","unstructured":"Huwez F.U.; Thirlwell D.; Cockayne A.; Ala\u2019Aldeen, D.A. Mastic gum kills Helicobacter pylori. N Engl J Med 1998,339(26),1946","journal-title":"N Engl J Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1179\/joc.2001.13.6.611","volume":"13","author":"Marone P.","year":"2001","unstructured":"Marone P.; Bono L.; Leone E.; Bona S.; Carretto E.; Perversi L.; Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. J Chemother 2001,13(6),611-614","journal-title":"J Chemother"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0002-9270(01)02891-X","volume":"96","author":"Bona S.G.","year":"2001","unstructured":"Bona S.G.; Bono L.; Daghetta L.; Marone P.; Bactericidal activity of Pistacia lentiscus gum mastic against Helicobacter pylori. Am J Gastroenterol 2001,96,S49","journal-title":"Am J Gastroenterol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/jac\/dkg057","volume":"51","author":"Loughlin M.F.","year":"2003","unstructured":"Loughlin M.F.; Ala\u2019Aldeen D.A.; Jenks P.J.; Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice. J Antimicrob Chemother 2003,51(2),367-371","journal-title":"J Antimicrob Chemother"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1128\/AAC.00642-06","volume":"51","author":"Paraschos S.","year":"2007","unstructured":"Paraschos S.; Magiatis P.; Mitakou S.; Petraki K.; Kalliaropoulos A.; Maragkoudakis P.; Mentis A.; Sgouras D.; Skaltsounis A-L.; In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother 2007,51(2),551-559","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1016\/S0040-4039(98)00228-7","volume":"39","author":"van den Berg J.K.","year":"1998","unstructured":"van den Berg J.K.; van der Horst J.; Boon J.J.; Sudmeijer O.O.; Cis-1,4-poly-\u03b2-myreene; the structure of the polymeric fraction of mastic resin (Pistacia lentiscus L.) elucidated. Tetrahedron Lett 1998,39(17),2645-2648","journal-title":"Tetrahedron Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/bmc.454","volume":"19","author":"Assimopoulou A.N.","year":"2005","unstructured":"Assimopoulou A.N.; Papageorgiou V.P.; GC-MS analysis of penta- and tetra-cyclic triterpenes from resins of Pistacia species. Part I. Pistacia lentiscus var. Chia. Biomed Chromatogr 2005,19(4),285-311","journal-title":"Biomed Chromatogr"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0021-9673(96)01032-1","volume":"769","author":"Papageorgiou V.P.","year":"1997","unstructured":"Papageorgiou V.P.; Bakola-Christianopoulou M.N.; Apazidou K.K.; Psarros E.E.; Gas chromatographic-mass spectroscopic analysis of the acidic triterpenic fraction of mastic gum. J Chromatogr A 1997,769(2),263-273","journal-title":"J Chromatogr A"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3181\/0811-RM-338","volume":"234","author":"Loizou S.","year":"2009","unstructured":"Loizou S.; Paraschos S.; Mitakou S.; Chrousos G.P.; Lekakis I.; Moutsatsou P.; Chios mastic gum extract and isolated phytosterol tirucallol exhibit anti-inflammatory activity in human aortic endothelial cells. Exp Biol Med (Maywood) 2009,234(5),553-561","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1081\/JLC-120027100","volume":"27","author":"Kaliora A.C.","year":"2004","unstructured":"Kaliora A.C.; Mylona A.; Chiou A.; Petsios D.G.; Andrikopoulos N.K.; Detection and identification of simple phenolics in Pistacia lentiscus resin. J Liq Chromatogr Relat Technol 2004,27(2),289-300","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/10412905.1991.9697918","volume":"3","author":"Papageorgiou V.","year":"1991","unstructured":"Papageorgiou V.; Mellidis A.; Argyriadou N.; The chemical composition of the essential oil of mastic gum. J Essent Oil Res 1991,3(2),107-110","journal-title":"J Essent Oil Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1055\/s-2006-960856","volume":"65","author":"Magiatis P.","year":"1999","unstructured":"Magiatis P.; Melliou E.; Skaltsounis A.L.; Chinou I.B.; Mitaku S.; Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. chia. Planta Med 1999,65(8),749-752","journal-title":"Planta Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.1021\/jf050639s","volume":"53","author":"Koutsoudaki C.","year":"2005","unstructured":"Koutsoudaki C.; Krsek M.; Rodger A.; Chemical composition and antibacterial activity of the essential oil and the gum of Pistacia lentiscus Var. chia. J Agric Food Chem 2005,53(20),7681-7685","journal-title":"J Agric Food Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s13659-014-0033-3","volume":"4","author":"Miyamoto T.","year":"2014","unstructured":"Miyamoto T.; Okimoto T.; Kuwano M.; Chemical composition of the essential oil of mastic gum and their antibacterial activity against drug-resistant Helicobacter pylori. Nat Prod Bioprospect 2014,4(4),227-231","journal-title":"Nat Prod Bioprospect"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00726-007-0554-8","volume":"34","author":"Kottakis F.","year":"2008","unstructured":"Kottakis F.; Lamari F.; Matragkou Ch.; Zachariadis G.; Karamanos N.; Choli-Papadopoulou T.; Arabino-galactan proteins from Pistacia lentiscus var. chia: isolation, characterization and biological function. Amino Acids 2008,34(3),413-420","journal-title":"Amino Acids"},{"key":"ref=93","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/263805","volume":"2013","author":"Puram S.","year":"2013","unstructured":"Puram S.; Suh H.C.; Kim S.U.; Bethapudi B.; Joseph J.A.; Agarwal A.; Kudiganti V.; Effect of GutGard in the management of Helicobacter pylori: a randomized double blind placebo controlled study. Evid Based Complement Alternat Med 2013,2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.phymed.2010.08.001","volume":"18","author":"Chandrasekaran C.V.","year":"2011","unstructured":"Chandrasekaran C.V.; Deepak H.B.; Thiyagarajan P.; Kathiresan S.; Sangli G.K.; Deepak M.; Agarwal A.; Dual inhibitory effect of Glycyrrhiza glabra (GutGard\u2122) on COX and LOX products. Phytomedicine 2011,18(4),278-284","journal-title":"Phytomedicine"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/gut.10.4.299","volume":"10","author":"Turpie A.G.","year":"1969","unstructured":"Turpie A.G.; Runcie J.; Thomson T.J.; Clinical trial of deglycyrrhizinized liquorice in gastric ulcer. Gut 1969,10(4),299-302","journal-title":"Gut"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/gut.9.1.48","volume":"9","author":"Tewari S.N.","year":"1968","unstructured":"Tewari S.N.; Trembalowicz F.C.; Some experience with deglycyrrhizinated liquorice in the treatment of gastric and duodenal ulcers with special reference to its spasmolytic effect. Gut 1968,9(1),48-51","journal-title":"Gut"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/gut.12.6.449","volume":"12","author":"Feldman H.","year":"1971","unstructured":"Feldman H.; Gilat T.; A trial of deglycyrrhizinated liquorice in the treatment of duodenal ulcer. Gut 1971,12(6),449-451","journal-title":"Gut"},{"key":"ref=98","first-page":"787","volume":"215","author":"Larkworthy W.","year":"1975","unstructured":"Larkworthy W.; Holgate P.F.L.; Deglycyrrhizinized liquorice in the treatment of chronic duodenal ulcer. A retrospective endoscopic survey of 32 patients. Practitioner 1975,215(1290),787-792","journal-title":"Practitioner"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/gut.19.9.779","volume":"19","author":"Bardhan K.D.","year":"1978","unstructured":"Bardhan K.D.; Cumberland D.C.; Dixon R.A.; Holdsworth C.D.; Clinical trial of deglycyrrhizinised liquorice in gastric ulcer. Gut 1978,19(9),779-782","journal-title":"Gut"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/bmj.1.6106.148","volume":"1","author":"Hollanders D.","year":"1978","unstructured":"Hollanders D.; Green G.; Woolf I.L.; Boyes B.E.; Wilson R.Y.; Cowley D.J.; Dymock I.W.; Prophylaxis with deglycyrrhizinised liquorice in patients with healed gastric ulcer. BMJ 1978,1(6106),148-148","journal-title":"BMJ"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.2.6095.1123","volume":"2","author":"Larkworthy W.","year":"1977","unstructured":"Larkworthy W.; Holgate P.F.; McIllmurray M.B.; Langman M.J.; Deglycyrrhizinised liquorice in duodenal ulcer. BMJ 1977,2(6095),1123","journal-title":"BMJ"},{"key":"ref=102","first-page":"427","volume":"41","author":"D\u2019Imperio N.","year":"1978","unstructured":"D\u2019Imperio N.; Giuliani Piccari G.; Sarti F.; Soffritti M.; Spongano P.; Benvenuti C.; Dal Monte P.R.; Double-blind trial in duodenal and gastric ulcers. Cimetidine and deglycyrrhizinized liquorice. Acta Gastroenterol Belg 1978,41(7-8),427-434","journal-title":"Acta Gastroenterol Belg"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/gut.23.6.545","volume":"23","author":"Morgan A.G.","year":"1982","unstructured":"Morgan A.G.; McAdam W.A.; Pacsoo C.; Darnborough A.; Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut 1982,23(6),545-551","journal-title":"Gut"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0024-3205(02)01864-7","volume":"71","author":"Fukai T.","year":"2002","unstructured":"Fukai T.; Marumo A.; Kaitou K.; Kanda T.; Terada S.; Nomura T.; Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci 2002,71(12),1449-1463","journal-title":"Life Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jep.2012.11.033","volume":"145","author":"Asha M.K.","year":"2013","unstructured":"Asha M.K.; Debraj D.; Prashanth D.; Edwin J.R.; Srikanth H.S.; Muruganantham N.; Dethe S.M.; Anirban B.; Jaya B.; Deepak M.; Agarwal A.; In vitro anti-Helicobacter pylori activity of a flavonoid rich extract of Glycyrrhiza glabra and its probable mechanisms of action. J Ethnopharmacol 2013,145(2),581-586","journal-title":"J Ethnopharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/19390211.2016.1223257","volume":"14","author":"Asha M.K.","year":"2017","unstructured":"Asha M.K.; Debraj D.; Dethe S.; Bhaskar A.; Muruganantham N.; Deepak M.; Effect of flavonoid-rich extract of Glycyrrhiza glabra on gut-friendly microorganisms, commercial probiotic preparations, and digestive enzymes. J Diet Suppl 2017,14(3),323-333","journal-title":"J Diet Suppl"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jep.2009.07.009","volume":"125","author":"Wittschier N.","year":"2009","unstructured":"Wittschier N.; Faller G.; Hensel A.; Aqueous extracts and polysaccharides from liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Ethnopharmacol 2009,125(2),218-223","journal-title":"J Ethnopharmacol"},{"key":"ref=108","author":"Lamont R.J.","year":"2006","unstructured":"Lamont R.J.; Burne R.A.; Lantz M.S.; LeBlanc J.D.; Oral Microbiol Immunol 2006","journal-title":"Oral Microbiol Immunol"},{"key":"ref=109","first-page":"e23","volume":"43","author":"Stingu C.S.","year":"2012","unstructured":"Stingu C.S.; Jentsch H.; Eick S.; Schaumann R.; Kn\u00f6fler G.; Rodloff A.; Microbial profile of patients with periodontitis compared with healthy subjects. Quintessence Int 2012,43(2),e23-e31","journal-title":"Quintessence Int"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/bmj.306.6879.688","volume":"306","author":"DeStefano F.","year":"1993","unstructured":"DeStefano F.; Anda R.F.; Kahn H.S.; Williamson D.F.; Russell C.M.; Dental disease and risk of coronary heart disease and mortality. BMJ 1993,306(6879),688-691","journal-title":"BMJ"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S1286-4579(00)00391-9","volume":"2","author":"Gendron R.","year":"2000","unstructured":"Gendron R.; Grenier D.; Maheu-Robert L.; The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect 2000,2(8),897-906","journal-title":"Microbes Infect"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.298.6676.779","volume":"298","author":"Mattila K.J.","year":"1989","unstructured":"Mattila K.J.; Nieminen M.S.; Valtonen V.V.; Rasi V.P.; Kes\u00e4niemi Y.A.; Syrj\u00e4l\u00e4 S.L.; Jungell P.S.; Isoluoma M.; Hietaniemi K.; Jokinen M.J.; Association between dental health and acute myocardial infarction. BMJ 1989,298(6676),779-781","journal-title":"BMJ"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/JCM.43.11.5721-5732.2005","volume":"43","author":"Aas J.A.","year":"2005","unstructured":"Aas J.A.; Paster B.J.; Stokes L.N.; Olsen I.; Dewhirst F.E.; Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005,43(11),5721-5732","journal-title":"J Clin Microbiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1099\/jmm.0.46417-0","volume":"55","author":"Colombo A.V.","year":"2006","unstructured":"Colombo A.V.; Silva C.M.; Haffajee A.; Colombo A.P.; Identification of oral bacteria associated with crevicular epithelial cells from chronic periodontitis lesions. J Med Microbiol 2006,55(Pt 5),609-615","journal-title":"J Med Microbiol"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1128\/IAI.66.12.6054-6057.1998","volume":"66","author":"Dorn B.R.","year":"1998","unstructured":"Dorn B.R.; Leung K.L.; Progulske-Fox A.; Invasion of human oral epithelial cells by Prevotella intermedia. Infect Immun 1998,66(12),6054-6057","journal-title":"Infect Immun"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1128\/IAI.68.6.3140-3146.2000","volume":"68","author":"Han Y.W.","year":"2000","unstructured":"Han Y.W.; Shi W.; Huang G.T.; Kinder Haake S.; Park N.H.; Kuramitsu H.; Genco R.J.; Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 2000,68(6),3140-3146","journal-title":"Infect Immun"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1034\/j.1399-302X.1999.140609.x","volume":"14","author":"Peters S.R.","year":"1999","unstructured":"Peters S.R.; Valdez M.; Riviere G.; Thomas D.D.; Adherence to and penetration through endothelial cells by oral treponemes. Oral Microbiol Immunol 1999,14(6),379-383","journal-title":"Oral Microbiol Immunol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/pmj.78.922.455","volume":"78","author":"Akpan A.","year":"2002","unstructured":"Akpan A.; Morgan R.; Oral candidiasis. Postgrad Med J 2002,78(922),455-459","journal-title":"Postgrad Med J"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1600-0757.2008.00253.x","volume":"48","author":"Addy M.","year":"2008","unstructured":"Addy M.; Oral hygiene products: potential for harm to oral and systemic health? Periodontol 2000 2008,48(48),54-65","journal-title":"Periodontol 2000"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4037\/ajcc2004.13.1.25","volume":"13","author":"Munro C.L.","year":"2004","unstructured":"Munro C.L.; Grap M.J.; Oral health and care in the intensive care unit: state of the science. Am J Crit Care 2004,13(1),25-33","journal-title":"Am J Crit Care"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1600-0757.1997.tb00102.x","volume":"15","author":"Forward G.C.","year":"1997","unstructured":"Forward G.C.; James A.H.; Barnett P.; Jackson R.J.; Gum health product formulations: what is in them and why? Periodontol 2000 1997,15(15),32-39","journal-title":"Periodontol 2000"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijantimicag.2008.07.014","volume":"33","author":"Allaker R.P.","year":"2009","unstructured":"Allaker R.P.; Douglas C.W.; Novel anti-microbial therapies for dental plaque-related diseases. Int J Antimicrob Agents 2009,33(1),8-13","journal-title":"Int J Antimicrob Agents"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/ptr.4606","volume":"26","author":"Vlachojannis C.","year":"2012","unstructured":"Vlachojannis C.; Magora F.; Chrubasik S.; Rise and fall of oral health products with Canadian bloodroot extract. Phytother Res 2012,26(10),1423-1426","journal-title":"Phytother Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/ptr.4762","volume":"27","author":"Vlachojannis C.","year":"2013","unstructured":"Vlachojannis C.; Winsauer H.; Chrubasik S.; Effectiveness and safety of a mouthwash containing essential oil ingredients. Phytother Res 2013,27(5),685-691","journal-title":"Phytother Res"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0002-8177(86)24021-0","volume":"112","year":"1986","unstructured":"Guidelines for acceptance of chemotherapeutic products for the control of supragingival dental plaque and gingivitis. J Am Dent Assoc 1986,112(4),529-532","journal-title":"J Am Dent Assoc"},{"key":"ref=126","year":"2008","unstructured":"Chemotherapeutic Prod-ucts for Control of Gingivitis Acceptance Program Guidelines2008","journal-title":"Chemotherapeutic Prod-ucts for Control of Gingivitis"},{"key":"ref=127","first-page":"351","volume":"15","author":"Sharma N.C.","year":"2002","unstructured":"Sharma N.C.; Charles C.H.; Qaqish J.G.; Galustians H.J.; Zhao Q.; Kumar L.D.; Comparative effectiveness of an essential oil mouthrinse and dental floss in controlling interproximal gingivitis and plaque. Am J Dent 2002,15(6),351-355","journal-title":"Am J Dent"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1600-051X.2004.00578.x","volume":"31","author":"Charles C.H.","year":"2004","unstructured":"Charles C.H.; Mostler K.M.; Bartels L.L.; Mankodi S.M.; Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 2004,31(10),878-884","journal-title":"J Clin Periodontol"},{"key":"ref=129","first-page":"175","volume":"60","author":"Sharma N.C.","year":"2010","unstructured":"Sharma N.C.; Araujo M.W.; Wu M.M.; Qaqish J.; Charles C.H.; Superiority of an essential oil mouthrinse when compared with a 0.05% cetylpyridinium chloride containing mouthrinse: a six-month study. Int Dent J 2010,60(3),175-180","journal-title":"Int Dent J"},{"key":"ref=130","first-page":"e82","volume":"43","author":"Cortelli S.C.","year":"2012","unstructured":"Cortelli S.C.; Cortelli J.R.; Wu M.M.; Simmons K.; Charles C.A.; Comparative antiplaque and antigingivitis efficacy of a multipurpose essential oil-containing mouthrinse and a cetylpyridinium chloride-containing mouthrinse: a 6-month randomized clinical trial. Quintessence Int 2012,43(7),e82-e94","journal-title":"Quintessence Int"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1601-5037.2012.00556.x","volume":"11","author":"Singh A.","year":"2013","unstructured":"Singh A.; Daing A.; Dixit J.; The effect of herbal, essential oil and chlorhexidine mouthrinse on de novo plaque formation. Int J Dent Hyg 2013,11(1),48-52","journal-title":"Int J Dent Hyg"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.14219\/jada.archive.2006.0110","volume":"137","author":"Gunsolley J.C.","year":"2006","unstructured":"Gunsolley J.C.; A meta-analysis of six-month studies of antiplaque and antigingivitis agents. J Am Dent Assoc 2006,137(12),1649-1657","journal-title":"J Am Dent Assoc"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1902\/jop.2007.060269","volume":"78","author":"Stoeken J.E.","year":"2007","unstructured":"Stoeken J.E.; Paraskevas S.; van der Weijden G.A.; The long-term effect of a mouthrinse containing essential oils on dental plaque and gingivitis: a systematic review. J Periodontol 2007,78(7),1218-1228","journal-title":"J Periodontol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1902\/jop.2010.100266","volume":"82","author":"Van Leeuwen M.P.","year":"2011","unstructured":"Van Leeuwen M.P.; Slot D.E.; Van der Weijden G.A.; Essential oils compared to chlorhexidine with respect to plaque and parameters of gingival inflammation: a systematic review. J Periodontol 2011,82(2),174-194","journal-title":"J Periodontol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/jac\/dkp362","volume":"64","author":"Hendry E.R.","year":"2009","unstructured":"Hendry E.R.; Worthington T.; Conway B.R.; Lambert P.A.; Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J Antimicrob Chemother 2009,64(6),1219-1225","journal-title":"J Antimicrob Chemother"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/s-2005-837790","volume":"71","author":"Cha J.D.","year":"2005","unstructured":"Cha J.D.; Jeong M.R.; Jeong S.I.; Moon S.E.; Kim J.Y.; Kil B.S.; Song Y.H.; Chemical composition and antimicrobial activity of the essential oils of Artemisia scoparia and A. capillaris. Planta Med 2005,71(2),186-190","journal-title":"Planta Med"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1515\/znc-2010-9-1009","volume":"65","author":"Bernardes W.A.","year":"2010","unstructured":"Bernardes W.A.; Lucarini R.; Tozatti M.G.; Flauzino L.G.; Souza M.G.; Turatti I.C.; Andrade e Silva M.L.; Martins C.H.; da Silva Filho A.A.; Cunha W.R.; Antibacterial activity of the essential oil from Rosmarinus officinalis and its major components against oral pathogens. Z Natforsch C J Biosci 2010,65(9-10),588-593","journal-title":"Z Natforsch C J Biosci"},{"key":"ref=138","first-page":"2061","volume":"17","author":"Cha J.D.","year":"2007","unstructured":"Cha J.D.; Jung E.K.; Kil B.S.; Lee K.Y.; Chemical composition and antibacterial activity of essential oil from Artemisia feddei. J Microbiol Biotechnol 2007,17(12),2061-2065","journal-title":"J Microbiol Biotechnol"},{"key":"ref=139","doi-asserted-by":"publisher","author":"Bhattacharya S.","unstructured":"Bhattacharya S.; Virani S.; Zavro M.; Haas G.J.; Inhibition of Streptococcus mutans and other oral streptococci by hop (Humulus lupulus L.) constituents. Econ. Bot., 2003, 57(1), 118-125.","DOI":"10.1663\/0013- 0001(2003)057[0118:IOSMAO]2.0.CO;2"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1590\/S0100-879X2007000300010","volume":"40","author":"Botelho M.A.","year":"2007","unstructured":"Botelho M.A.; Nogueira N.A.; Bastos G.M.; Fonseca S.G.; Lemos T.L.; Matos F.J.; Montenegro D.; Heukelbach J.; Rao V.S.; Brito G.A.; Antimicrobial activity of the essential oil from Lippia sidoides, carvacrol and thymol against oral pathogens. Braz J Med Biol Res 2007,40(3),349-356","journal-title":"Braz J Med Biol Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1399-302X.2005.00216.x","volume":"20","author":"Filoche S.K.","year":"2005","unstructured":"Filoche S.K.; Soma K.; Sissons C.H.; Antimicrobial effects of essential oils in combination with chlorhexidine digluconate. Oral Microbiol Immunol 2005,20(4),221-225","journal-title":"Oral Microbiol Immunol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/08927014.2012.749398","volume":"29","author":"Raut J.S.","year":"2013","unstructured":"Raut J.S.; Shinde R.B.; Chauhan N.M.; Karuppayil S.M.; Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans. Biofouling 2013,29(1),87-96","journal-title":"Biofouling"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.4014\/jmb.1402.02056","volume":"24","author":"Raut J.S.","year":"2014","unstructured":"Raut J.S.; Shinde R.B.; Chauhan N.M.; Karuppayil S.M.; Phenylpropanoids of plant origin as inhibitors of biofilm formation by Candida albicans. J Microbiol Biotechnol 2014,24(9),1216-1225","journal-title":"J Microbiol Biotechnol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3314\/jjmm.50.243","volume":"50","author":"Inouye S.","year":"2009","unstructured":"Inouye S.; Takahashi M.; Abe S.; Inhibitory activity of hydrosols, herbal teas and related essential oils against filament formation and the growth of Candida albicans. Nippon Ishinkin Gakkai Zasshi 2009,50(4),243-251","journal-title":"Nippon Ishinkin Gakkai Zasshi"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fmed.2018.00028","volume":"5","author":"Cavalheiro M.","year":"2018","unstructured":"Cavalheiro M.; Teixeira M.C.; Candida biofilms: threats, challenges, and promising strategies. Front Med (Lausanne) 2018,5,28","journal-title":"Front Med (Lausanne)"},{"key":"ref=146","first-page":"301","volume":"31","author":"Kato T.","year":"1990","unstructured":"Kato T.; Iijima H.; Ishihara K.; Kaneko T.; Hirai K.; Naito Y.; Okuda K.; Antibacterial effects of Listerine on oral bacteria. Bull Tokyo Dent Coll 1990,31(4),301-307","journal-title":"Bull Tokyo Dent Coll"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1034\/j.1600-0528.2002.00061.x","volume":"30","author":"Baca P.","year":"2002","unstructured":"Baca P.; Mu\u00f1oz M.J.; Bravo M.; Junco P.; Baca A.P.; Effectiveness of chlorhexidine-thymol varnish for caries reduction in permanent first molars of 6-7-year-old children: 24-month clinical trial. Community Dent Oral Epidemiol 2002,30(5),363-368","journal-title":"Community Dent Oral Epidemiol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1034\/j.1600-0528.2003.00034.x","volume":"31","author":"Baca P.","year":"2003","unstructured":"Baca P.; Junco P.; Bravo M.; Baca A.P.; Mu\u00f1oz M.J.; Caries incidence in permanent first molars after discontinuation of a school-based chlorhexidine-thymol varnish program. Community Dent Oral Epidemiol 2003,31(3),179-183","journal-title":"Community Dent Oral Epidemiol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000065961","volume":"36","author":"Araujo A.M.","year":"2002","unstructured":"Araujo A.M.; Naspitz G.M.; Chelotti A.; Cai S.; Effect of Cervitec on mutans streptococci in plaque and on caries formation on occlusal fissures of erupting permanent molars. Caries Res 2002,36(5),373-376","journal-title":"Caries Res"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0300-5712(00)00060-9","volume":"29","author":"Joharji R.M.","year":"2001","unstructured":"Joharji R.M.; Adenubi J.O.; Prevention of pit and fissure caries using an antimicrobial varnish: 9 month clinical evaluation. J Dent 2001,29(4),247-254","journal-title":"J Dent"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000262397","volume":"31","author":"Twetman S.","year":"1997","unstructured":"Twetman S.; Petersson L.G.; Effect of different chlorhexidine varnish regimens on mutans streptococci levels in interdental plaque and saliva. Caries Res 1997,31(3),189-193","journal-title":"Caries Res"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000262067","volume":"29","author":"Twetman S.","year":"1995","unstructured":"Twetman S.; Hallgren A.; Petersson L.G.; Effect of an antibacterial varnish on mutans streptococci in plaque from enamel adjacent to orthodontic appliances. Caries Res 1995,29(3),188-191","journal-title":"Caries Res"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.4317\/medoral.18261","volume":"18","author":"Baygin O.","year":"2013","unstructured":"Baygin O.; Tuzuner T.; Ozel M.B.; Bostanoglu O.; Comparison of combined application treatment with one-visit varnish treatments in an orthodontic population. Med Oral Patol Oral Cir Bucal 2013,18(2),e362-e370","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000261984","volume":"28","author":"Weiger R.","year":"1994","unstructured":"Weiger R.; Friedrich C.; Netuschil L.; Schlagenhauf U.; Effect of chlorhexidine-containing varnish (Cervitec) on microbial vitality and accumulation of supragingival dental plaque in humans. Caries Res 1994,28(4),267-271","journal-title":"Caries Res"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0300-5712(02)00045-3","volume":"30","author":"Brailsford S.R.","year":"2002","unstructured":"Brailsford S.R.; Fiske J.; Gilbert S.; Clark D.; Beighton D.; The effects of the combination of chlorhexidine\/thymol- and fluoride-containing varnishes on the severity of root caries lesions in frail institutionalised elderly people. J Dent 2002,30(7-8),319-324","journal-title":"J Dent"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jdent.2009.05.001","volume":"37","author":"Baca P.","year":"2009","unstructured":"Baca P.; Clavero J.; Baca A.P.; Gonz\u00e1lez-Rodr\u00edguez M.P.; Bravo M.; Valderrama M.J.; Effect of chlorhexidine-thymol varnish on root caries in a geriatric population: a randomized double-blind clinical trial. J Dent 2009,37(9),679-685","journal-title":"J Dent"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000070442","volume":"37","author":"Haukali G.","year":"2003","unstructured":"Haukali G.; Poulsen S.; Effect of a varnish containing chlorhexidine and thymol (Cervitec) on approximal caries in 13- to 16-year-old schoolchildren in a low caries area. Caries Res 2003,37(3),185-189","journal-title":"Caries Res"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000315346","volume":"44","author":"James P.","year":"2010","unstructured":"James P.; Parnell C.; Whelton H.; The caries-preventive effect of chlorhexidine varnish in children and adolescents: a systematic review. Caries Res 2010,44(4),333-340","journal-title":"Caries Res"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1600-0722.2006.00392.x","volume":"114","author":"Zhang Q.","year":"2006","unstructured":"Zhang Q.; van Palenstein Helderman W.H.; van\u2019t Hof M.A.; Truin G.J.; Chlorhexidine varnish for preventing dental caries in children, adolescents and young adults: a systematic review. Eur J Oral Sci 2006,114(6),449-455","journal-title":"Eur J Oral Sci"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000262136","volume":"30","author":"van Loveren C.","year":"1996","unstructured":"van Loveren C.; Buijs J.F.; Buijs M.J.; ten Cate J.M.; Protection of bovine enamel and dentine by chlorhexidine and fluoride varnishes in a bacterial demineralization model. Caries Res 1996,30(1),45-51","journal-title":"Caries Res"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1600-0722.2007.00493.x","volume":"115","author":"Takeuchi Y.","year":"2007","unstructured":"Takeuchi Y.; Guggenheim B.; Filieri A.; Baehni P.; Effect of chlorhexidine\/thymol and fluoride varnishes on dental biofilm formation in vitro. Eur J Oral Sci 2007,115(6),468-472","journal-title":"Eur J Oral Sci"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.4317\/medoral.17680","volume":"17","author":"Arias-Moliz M.T.","year":"2012","unstructured":"Arias-Moliz M.T.; Ferrer-Luque C.M.; Gonz\u00e1lez-Rodr\u00edguez M.P.; Navarro-Escobar E.; de Freitas M.F.A.; Baca P.; Antimicrobial activity and enterococcus faecalis biofilm formation on chlorhexidine varnishes. Med Oral Patol Oral Cir Bucal 2012,17(4),e705-e709","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/jac\/dkn325","volume":"62","author":"Karpanen T.J.","year":"2008","unstructured":"Karpanen T.J.; Worthington T.; Hendry E.R.; Conway B.R.; Lambert P.A.; Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis. J Antimicrob Chemother 2008,62(5),1031-1036","journal-title":"J Antimicrob Chemother"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1034\/j.1600-051X.2002.290705.x","volume":"29","author":"Arweiler N.B.","year":"2002","unstructured":"Arweiler N.B.; Auschill T.M.; Reich E.; Netuschil L.; Substantivity of toothpaste slurries and their effect on reestablishment of the dental biofilm. J Clin Periodontol 2002,29(7),615-621","journal-title":"J Clin Periodontol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1590\/S1806-83242006000200015","volume":"20","author":"Ozaki F.","year":"2006","unstructured":"Ozaki F.; Pannuti C.M.; Imbronito A.V.; Pessotti W.; Saraiva L.; de Freitas N.M.; Ferrari G.; Cabral V.N.; Efficacy of a herbal toothpaste on patients with established gingivitis--a randomized controlled trial. Braz Oral Res 2006,20(2),172-177","journal-title":"Braz Oral Res"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7243\/2050-120X-1-7","volume":"1","author":"Badiee P.","year":"2012","unstructured":"Badiee P.; Nasirzadeh A.R.; Motaffaf M.; Comparison of Salvia officinalis L. essential oil and antifungal agents against candida species. J Pharm Technol Drug Res 2012,1,7","journal-title":"J Pharm Technol Drug Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S2221-1691(13)60080-5","volume":"3","author":"Sookto T.","year":"2013","unstructured":"Sookto T.; Srithavaj T.; Thaweboon S.; Thaweboon B.; Shrestha B.; Nakazawa F.; In vitro effects of Salvia officinalis L. essential oil on Candida albicans. Asian Pac J Trop Biomed 2013,3(5),376-380","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3923\/rjmp.2013.100.106","volume":"7","author":"Kraivaphan P.","year":"2013","unstructured":"Kraivaphan P.; Amornchat C.; Maneepitsamai Y.; Bactericidal effects of three mint essential oils on Porphyromonas gingivalis in planktonic and biofilm cells. Res J Med Plant 2013,7(2),100-106","journal-title":"Res J Med Plant"},{"key":"ref=169","first-page":"A30","volume":"1","author":"Renggli H.H.","year":"1988","unstructured":"Renggli H.H.; The effect of Parodontax mouthwash and its constituents on the microorganisms of subgingival plaque. J Clin Dent 1988,1(Suppl. A),A30-A33","journal-title":"J Clin Dent"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S2221-1691(12)60059-8","volume":"2","author":"Adwan G.","year":"2012","unstructured":"Adwan G.; Salameh Y.; Adwan K.; Barakat A.; Assessment of antifungal activity of herbal and conventional toothpastes against clinical isolates of Candida albicans. Asian Pac J Trop Biomed 2012,2(5),375-379","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jdent.2010.12.007","volume":"39","author":"Verkaik M.J.","year":"2011","unstructured":"Verkaik M.J.; Busscher H.J.; Jager D.; Slomp A.M.; Abbas F.; van der Mei H.C.; Efficacy of natural antimicrobials in toothpaste formulations against oral biofilms in vitro. J Dent 2011,39(3),218-224","journal-title":"J Dent"},{"key":"ref=172","first-page":"132","volume":"3","author":"Babpour E.","year":"2009","unstructured":"Babpour E.; Angaji S.A.; Angaji S.M.; Antimicrobial effects of four medicinal plants on dental plaque. J Med Plants Res 2009,3(3),132-137","journal-title":"J Med Plants Res"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.anaerobe.2009.02.004","volume":"15","author":"Gursoy U.K.","year":"2009","unstructured":"Gursoy U.K.; Gursoy M.; Gursoy O.V.; Cakmakci L.; K\u00f6n\u00f6nen E.; Uitto V.J.; Anti-biofilm properties of Satureja hortensis L. essential oil against periodontal pathogens. Anaerobe 2009,15(4),164-167","journal-title":"Anaerobe"},{"key":"ref=174","first-page":"4147","volume":"5","author":"Noumi E.","year":"2011","unstructured":"Noumi E.; Snoussi M.; Hajlaoui H.; Trabelsi N.; Ksouri R.; Valentin E.; Bakhrouf A.; Chemical composition, antioxidant and antifungal potential of Melaleuca alternifolia (tea tree) and Eucalyptus globulus essential oils against oral Candida species. J Med Plants Res 2011,5(17),4147-4156","journal-title":"J Med Plants Res"},{"key":"ref=175","first-page":"179","volume":"36","author":"Namiranian H.","year":"2012","unstructured":"Namiranian H.; Serino G.; The effect of a toothpaste containing aloe vera on established gingivitis. Swed Dent J 2012,36(4),179-185","journal-title":"Swed Dent J"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1590\/S1678-77572012000100007","volume":"20","author":"Bertolini P.F.R.","year":"2012","unstructured":"Bertolini P.F.R.; Biondi Filho O.; Pomilio A.; Pinheiro S.L.; Carvalho M.S.; Antimicrobial capacity of Aloe vera and propolis dentifrice against Streptococcus mutans strains in toothbrushes: an in vitro study. J Appl Oral Sci 2012,20(1),32-37","journal-title":"J Appl Oral Sci"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jep.2003.09.035","volume":"90","author":"Pai M.R.","year":"2004","unstructured":"Pai M.R.; Acharya L.D.; Udupa N.; Evaluation of antiplaque activity of Azadirachta indica leaf extract gel--a 6-week clinical study. J Ethnopharmacol 2004,90(1),99-103","journal-title":"J Ethnopharmacol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4041\/kjod.2009.39.3.177","volume":"39","author":"Hussein E.A.","year":"2009","unstructured":"Hussein E.A.; Acar A.; Dogan A.A.; Kadir T.; Caldemir S.; Erverdi N.; Investigation of bacteremia after toothbrushing in orthodontic patients. Korean J Orthod 2009,39(3),177-184","journal-title":"Korean J Orthod"},{"key":"ref=179","first-page":"564","volume":"66","author":"Goldstein B.H.","year":"2000","unstructured":"Goldstein B.H.; Epstein J.B.; Unconventional dentistry: Part IV. Unconventional dental practices and products. J Can Dent Assoc 2000,66(10),564-568","journal-title":"J Can Dent Assoc"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.fitote.2015.07.016","volume":"105","author":"Pilna J.","year":"2015","unstructured":"Pilna J.; Vlkova E.; Krofta K.; Nesvadba V.; Rada V.; Kokoska L.; In vitro growth-inhibitory effect of ethanol GRAS plant and supercritical CO hop extracts on planktonic cultures of oral pathogenic microorganisms. Fitoterapia 2015,105,260-268","journal-title":"Fitoterapia"},{"key":"ref=181","author":"Dasaraju P.V.","year":"1996","unstructured":"Dasaraju P.V.; Liu C.; Medical Microbiology 1996","journal-title":"Medical Microbiology"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"Walsh T.J.","year":"2008","unstructured":"Walsh T.J.; Anaissie E.J.; Denning D.W.; Herbrecht R.; Kontoyiannis D.P.; Marr K.A.; Morrison V.A.; Segal B.H.; Steinbach W.J.; Stevens D.A.; van Burik J.A.; Wingard J.R.; Patterson T.F.; Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008,46(3),327-360","journal-title":"Clin Infect Dis"},{"key":"ref=183","year":"2010","unstructured":"Guidelines 2010","journal-title":"Guidelines"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0973-7847.194045","volume":"10","author":"Paparoupa M.","year":"2016","unstructured":"Paparoupa M.; Gillissen A.; Is Myrtol standardized a new alternative toward antibiotics? Pharmacogn Rev 2016,10(20),143-146","journal-title":"Pharmacogn Rev"},{"key":"ref=185","first-page":"990","volume":"48","author":"Sengespeik H.C.","year":"1998","unstructured":"Sengespeik H.C.; Zimmermann T.; Peiske C.; de Mey C.; Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study Arzneimittelforschung 1998,48(10),990-994","journal-title":"Arzneimittelforschung"},{"key":"ref=186","first-page":"351","volume":"49","author":"Meister R.","year":"1999","unstructured":"Meister R.; Wittig T.; Beuscher N.; de Mey C.; Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Arzneimittelforschung 1999,49(4),351-358","journal-title":"Arzneimittelforschung"},{"key":"ref=187","first-page":"700","volume":"50","author":"Matthys H.","year":"2000","unstructured":"Matthys H.; de Mey C.; Carls C.; Ry\u015b A.; Geib A.; Wittig T.; Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung 2000,50(8),700-711","journal-title":"Arzneimittelforschung"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/jac\/47.5.565","volume":"47","author":"Inouye S.","year":"2001","unstructured":"Inouye S.; Takizawa T.; Yamaguchi H.; Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J Antimicrob Chemother 2001,47(5),565-573","journal-title":"J Antimicrob Chemother"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/ffj.1843","volume":"22","author":"Van Vuuren S.F.","year":"2007","unstructured":"Van Vuuren S.F.; Viljoen A.M.; Antimicrobial activity of limonene enantiomers and 1,8-cineole alone and in combination. Flavour Fragrance J 2007,22(6),540-544","journal-title":"Flavour Fragrance J"},{"key":"ref=190","first-page":"652","volume":"56","author":"Kemmerich B.","year":"2006","unstructured":"Kemmerich B.; Eberhardt R.; Stammer H.; Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung 2006,56(9),652-660","journal-title":"Arzneimittelforschung"},{"key":"ref=191","first-page":"607","volume":"57","author":"Kemmerich B.","year":"2007","unstructured":"Kemmerich B.; Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung 2007,57(9),607-615","journal-title":"Arzneimittelforschung"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2174\/1389557516666160211120540","volume":"16","author":"Guin\u00e9 R.P.","year":"2016","unstructured":"Guin\u00e9 R.P.; Gon\u00e7alves F.J.; Bioactive compounds in some culinary aromatic herbs and their effects on human health. Mini Rev Med Chem 2016,16(11),855-866","journal-title":"Mini Rev Med Chem"},{"key":"ref=193","first-page":"309","volume":"5","author":"Mohsenipour Z.","year":"2015","unstructured":"Mohsenipour Z.; Hassanshahian M.; The inhibitory effect of Thymus vulgaris extracts on the planktonic form and biofilm structures of six human pathogenic bacteria. Avicenna J Phytomed 2015,5(4),309-318","journal-title":"Avicenna J Phytomed"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1055\/s-0035-1545879","volume":"81","author":"Lang C.","year":"2015","unstructured":"Lang C.; R\u00f6ttger-L\u00fcer P.; Staiger C.; valuable option for the treatment of respiratory diseases: review on the clinical evidence of the ivy leaves dry extract EA 575. Planta Med 2015,81(12-13),968-974","journal-title":"Planta Med"},{"key":"ref=195","first-page":"609","volume":"33","author":"Cioac\u00e1 C.","year":"1978","unstructured":"Cioac\u00e1 C.; Margineanu C.; Cucu V.; The saponins of Hedera helix with antibacterial activity. Pharmazie 1978,33(9),609-610","journal-title":"Pharmazie"},{"key":"ref=196","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0028-1097277","volume":"36","author":"Ieven M.","year":"1979","unstructured":"Ieven M.; Vanden Berghe D.A.; Mertens F.; Vlietinck A.; Lammens E.; Screening of higher plants for biological activities. I. Antimicrobial activity. Planta Med 1979,36(4),311-321","journal-title":"Planta Med"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6882-11-16","volume":"11","author":"Krawitz C.","year":"2011","unstructured":"Krawitz C.; Mraheil M.A.; Stein M.; Imirzalioglu C.; Domann E.; Pleschka S.; Hain T.; Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med 2011,11,16","journal-title":"BMC Complement Altern Med"},{"key":"ref=198","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000091087","volume":"13","author":"Melzer J.","year":"2006","unstructured":"Melzer J.; Saller R.; Schapowal A.; Brignoli R.; Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch Komplement Med 2006,13(2),78-87","journal-title":"Forsch Komplement Med"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1021\/jf0103572","volume":"49","author":"Yildirim A.","year":"2001","unstructured":"Yildirim A.; Mavi A.; Kara A.A.; Determination of antioxidant and antimicrobial activities of Rumex crispus L. extracts. J Agric Food Chem 2001,49(8),4083-4089","journal-title":"J Agric Food Chem"},{"key":"ref=200","author":"Bonn G.","unstructured":"Bonn G.; Stecher G.; Popp M.A.; Mayer R.; Hydrolysates made of plant extracts and antibacterial agent containing the same. U. S. Patent 0,147,502., 2014."},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"Hay R.J.","year":"2014","unstructured":"Hay R.J.; Johns N.E.; Williams H.C.; Bolliger I.W.; Dellavalle R.P.; Margolis D.J.; Marks R.; Naldi L.; Weinstock M.A.; Wulf S.K.; Michaud C.J.L.; Murray C.; Naghavi M.; The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014,134(6),1527-1534","journal-title":"J Invest Dermatol"},{"key":"ref=202","first-page":"141","volume":"30","author":"Dawson A.L.","year":"2012","unstructured":"Dawson A.L.; Dellavalle R.P.; Elston D.M.; Infectious skin diseases: a review and needs assessment. Dermatol Clin [ix-x].2012,30(1),141-151","journal-title":"Dermatol Clin"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1468-3083.2011.04416.x","volume":"26","author":"Tognetti L.","year":"2012","unstructured":"Tognetti L.; Martinelli C.; Berti S.; Hercogova J.; Lotti T.; Leoncini F.; Moretti S.; Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: a collaboration between dermatologists and infectivologists. J Eur Acad Dermatol Venereol 2012,26(8),931-941","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-7922-9-1","volume":"9","author":"Sartelli M.","year":"2014","unstructured":"Sartelli M.; Malangoni M.A.; May A.K.; Viale P.; Kao L.S.; Catena F.; Ansaloni L.; Moore E.E.; Moore F.A.; Peitzman A.B.; Coimbra R.; Leppaniemi A.; Kluger Y.; Biffl W.; Koike K.; Girardis M.; Ordonez C.A.; Yuan K.C.; World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg 2014,9(57),1-18","journal-title":"World J Emerg Surg"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bmj.319.7202.79","volume":"319","author":"Hart R.","year":"1999","unstructured":"Hart R.; Bell-Syer S.E.M.; Crawford F.; Torgerson D.J.; Young P.; Russell I.; Russell I.; Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ 1999,319(7202),79-82","journal-title":"BMJ"},{"key":"ref=206","first-page":"229","volume":"50","author":"Holti G.","year":"1970","unstructured":"Holti G.; A double-blind controlled trial of Whitfield\u2019s ointment and Variotin in ringworm infections with a two year \u201cfollow-up\u201d. Acta Derm Venereol 1970,50(3),229-231","journal-title":"Acta Derm Venereol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archderm.1977.01640060145029","volume":"113","author":"Clayton R.","year":"1977","unstructured":"Clayton R.; Du Vivier A.; Savage M.; Double-blind trial of 1% clotrimazole cream and Whitfield ointment in the treatment of pityriasis versicolor. Arch Dermatol 1977,113(6),849-850","journal-title":"Arch Dermatol"},{"key":"ref=208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/pgmj.50.580.73","volume":"50","author":"Comaish J.S.","year":"1974","unstructured":"Comaish J.S.; Double-blind comparison of clotrimazole with Whitfield\u2019s and nystatin ointments. Postgrad Med J 1974,50(Suppl. 1),73-75","journal-title":"Postgrad Med J"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2133.1973.tb02978.x","volume":"89","author":"Clayton Y.M.","year":"1973","unstructured":"Clayton Y.M.; Connor B.L.; Comparison of clotrimazole cream, Whitfield\u2019s ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis. Br J Dermatol 1973,89(3),297-303","journal-title":"Br J Dermatol"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1439-0507.1979.tb01675.x","volume":"22","author":"Sivayathorn A.","year":"1979","unstructured":"Sivayathorn A.; Piamphongsant T.; Topical antimycotic agents for the treatment of superficial dermatophytoses in Thailand--a double-blind study. Mykosen 1979,22(1),21-24","journal-title":"Mykosen"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2230.1986.tb00477.x","volume":"11","author":"Wright S.","year":"1986","unstructured":"Wright S.; Robertson V.J.; An institutional survey of tinea capitis in Harare, Zimbabwe and a trial of miconazole cream versus Whitfield\u2019s ointment in its treatment. Clin Exp Dermatol 1986,11(4),371-377","journal-title":"Clin Exp Dermatol"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-4362.1994.tb01524.x","volume":"33","author":"Gooskens V.","year":"1994","unstructured":"Gooskens V.; P\u00f6nnighaus J.M.; Clayton Y.; Mkandawire P.; Sterne J.A.; Treatment of superficial mycoses in the tropics: Whitfield\u2019s ointment versus clotrimazole. Int J Dermatol 1994,33(10),738-742","journal-title":"Int J Dermatol"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"622","DOI":"10.4103\/0253-7613.121378","volume":"45","author":"Thaker S.J.","year":"2013","unstructured":"Thaker S.J.; Mehta D.S.; Shah H.A.; Dave J.N.; Kikani K.M.; A comparative study to evaluate efficacy, safety and cost-effectiveness between Whitfield\u2019s ointment + oral fluconazole versus topical 1% butenafine in tinea infections of skin. Indian J Pharmacol 2013,45(6),622-624","journal-title":"Indian J Pharmacol"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1472-765X.2003.01370.x","volume":"37","author":"Chowdhury B.","year":"2003","unstructured":"Chowdhury B.; Adak M.; Bose S.K.; Flurbiprofen, a unique non-steroidal anti-inflammatory drug with antimicrobial activity against Trichophyton, Microsporum and Epidermophyton species. Lett Appl Microbiol 2003,37(2),158-161","journal-title":"Lett Appl Microbiol"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1080\/10408398.2015.1087964","volume":"57","author":"Del Olmo A.","year":"2017","unstructured":"Del Olmo A.; Calzada J.; Nu\u00f1ez M.; Benzoic acid and its derivatives as naturally occurring compounds in foods and as additives: Uses, exposure, and controversy. Crit Rev Food Sci Nutr 2017,57(14),3084-3103","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1590\/S1984-82502013000400004","volume":"49","author":"Bertanha C.S.","year":"2013","unstructured":"Bertanha C.S.; Utrera S.H.; Gimenez V.M.M.; Groppo M.; Silva M.L.A.; Cunha W.R.; Martins C.H.G.; Januario A.H.; Pauletti P.M.; Antibacterial evaluation of Styrax pohlii and isolated compounds. Braz J Pharm Sci 2013,49(4),653-658","journal-title":"Braz J Pharm Sci"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0738-081X(95)00119-Z","volume":"14","author":"Shapiro J.","year":"1996","unstructured":"Shapiro J.; Maddin S.; Medicated shampoos. Clin Dermatol 1996,14(1),123-128","journal-title":"Clin Dermatol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajic.2004.07.012","volume":"33","author":"Guthery E.","year":"2005","unstructured":"Guthery E.; Seal L.A.; Anderson E.L.; Zinc pyrithione in alcohol-based products for skin antisepsis: persistence of antimicrobial effects. Am J Infect Control 2005,33(1),15-22","journal-title":"Am J Infect Control"},{"key":"ref=219","first-page":"433","volume":"39","author":"Han G.Y.","year":"1981","unstructured":"Han G.Y.; Xu P.X.; Wang X.P.; Liu M.Z.; Xu X.Y.; Meng L.N.; Chen Z.L.; Zhu D.Y.; Studies on active principles of Polyalthia nemoralis. The isolation and identification of natural zinc compound. Acta Chimi Sin 1981,39(5),433-437","journal-title":"Acta Chimi Sin"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jep.2014.03.066","volume":"154","author":"Krej\u010dov\u00e1 P.","year":"2014","unstructured":"Krej\u010dov\u00e1 P.; Ku\u010derov\u00e1 P.; Stafford G.I.; J\u00e4ger A.K.; Kubec R.; Antiinflammatory and neurological activity of pyrithione and related sulfur-containing pyridine N-oxides from Persian shallot (Allium stipitatum). J Ethnopharmacol 2014,154(1),176-182","journal-title":"J Ethnopharmacol"},{"key":"ref=221","first-page":"875","volume":"47","author":"Park J.","year":"2009","unstructured":"Park J.; Kim B.J.; Kim M.N.; Hong Y.P.; Ju J.H.; Lee J.P.; Sohn K.H.; Park K.L.; Lee E.C.; Chun Y.J.; Clinical efficacy for 1% zinc pyrithione shampoo for the treatment of dandruff. Korean J Dermatol 2009,47(8),875-883","journal-title":"Korean J Dermatol"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1468-2494.2010.00623.x","volume":"33","author":"Schmidt-Rose T.","year":"2011","unstructured":"Schmidt-Rose T.; Braren S.; F\u00f6lster H.; Hillemann T.; Oltrogge B.; Philipp P.; Weets G.; Fey S.; Efficacy of a piroctone olamine\/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Int J Cosmet Sci 2011,33(3),276-282","journal-title":"Int J Cosmet Sci"},{"key":"ref=223","first-page":"558","volume":"16","author":"Lorette G.","year":"2006","unstructured":"Lorette G.; Ermosilla V.; Clinical efficacy of a new ciclopiroxolamine\/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. Eur J Dermatol 2006,16(5),558-564","journal-title":"Eur J Dermatol"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1467-2494.2003.00183.x","volume":"25","author":"Bailey P.","year":"2003","unstructured":"Bailey P.; Arrowsmith C.; Darling K.; Dexter J.; Eklund J.; Lane A.; Little C.; Murray B.; Scott A.; Williams A.; Wilson D.; A double-blind randomized vehicle-controlled clinical trial investigating the effect of ZnPTO dose on the scalp vs. antidandruff efficacy and antimycotic activity. Int J Cosmet Sci 2003,25(4),183-188","journal-title":"Int J Cosmet Sci"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/ics.12055","volume":"35","author":"Schwartz J.R.","year":"2013","unstructured":"Schwartz J.R.; Bacon R.A.; Shah R.; Mizoguchi H.; Tosti A.; Therapeutic efficacy of anti-dandruff shampoos: a randomized clinical trial comparing products based on potentiated zinc pyrithione and zinc pyrithione\/climbazole. Int J Cosmet Sci 2013,35(4),381-387","journal-title":"Int J Cosmet Sci"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0190-9622(90)70140-D","volume":"22","author":"Van Cutsem J.","year":"1990","unstructured":"Van Cutsem J.; Van Gerven F.; Fransen J.; Schrooten P.; Janssen P.A.J.; The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J Am Acad Dermatol 1990,22(6 Pt 1),993-998","journal-title":"J Am Acad Dermatol"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s001050050105","volume":"45","author":"Nenoff P.","year":"1994","unstructured":"Nenoff P.; Haustein U-F.; Effect of anti-seborrhea substances against Pityrosporum ovale in vitro Hautarzt 1994,45(7),464-467","journal-title":"Hautarzt"},{"key":"ref=228","first-page":"442","volume":"46","author":"Schmidt A.","year":"1996","unstructured":"Schmidt A.; R\u00fchl-H\u00f6rster B.; In vitro susceptibility of Malassezia furfur. Arzneimittelforschung 1996,46(4),442-444","journal-title":"Arzneimittelforschung"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11046-006-0075-0","volume":"162","author":"Roques C.","year":"2006","unstructured":"Roques C.; Brousse S.; Panizzutti C.; In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains. Mycopathologia 2006,162(6),395-400","journal-title":"Mycopathologia"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/ics.12098","volume":"36","author":"Onlom C.","year":"2014","unstructured":"Onlom C.; Khanthawong S.; Waranuch N.; Ingkaninan K.; In vitro anti-Malassezia activity and potential use in anti-dandruff formulation of Asparagus racemosus. Int J Cosmet Sci 2014,36(1),74-78","journal-title":"Int J Cosmet Sci"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00509065","volume":"272","author":"McGinley K.J.","year":"1982","unstructured":"McGinley K.J.; Leyden J.J.; Antifungal activity of dermatological shampoos. Arch Dermatol Res 1982,272(3-4),339-342","journal-title":"Arch Dermatol Res"},{"key":"ref=232","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5694\/j.1326-5377.1990.tb126150.x","volume":"153","author":"Bassett I.B.","year":"1990","unstructured":"Bassett I.B.; Pannowitz D.L.; Barnetson R.S.; A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990,153(8),455-458","journal-title":"Med J Aust"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0378-6323.30646","volume":"73","author":"Enshaieh S.","year":"2007","unstructured":"Enshaieh S.; Jooya A.; Siadat A.H.; Iraji F.; The efficacy of 5% topical tea tree oil gel in mild to moderate Acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol 2007,73(1),22-25","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jhin.2004.01.008","volume":"56","author":"Dryden M.S.","year":"2004","unstructured":"Dryden M.S.; Dailly S.; Crouch M.; A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 2004,56(4),283-286","journal-title":"J Hosp Infect"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/jac\/dks501","volume":"68","author":"Blackwood B.","year":"2013","unstructured":"Blackwood B.; Thompson G.; McMullan R.; Stevenson M.; Riley T.V.; Alderdice F.A.; Trinder T.J.; Lavery G.G.; McAuley D.F.; Tea tree oil (5%) body wash versus standard care (Johnson\u2019s Baby Softwash) to prevent colonization with methicillin-resistant Staphylococcus aureus in critically ill adults: a randomized controlled trial. J Antimicrob Chemother 2013,68(5),1193-1199","journal-title":"J Antimicrob Chemother"},{"key":"ref=236","first-page":"601","volume":"38","author":"Buck D.S.","year":"1994","unstructured":"Buck D.S.; Nidorf D.M.; Addino J.G.; Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 1994,38(6),601-605","journal-title":"J Fam Pract"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1046\/j.1365-3156.1999.00396.x","volume":"4","author":"Syed T.A.","year":"1999","unstructured":"Syed T.A.; Qureshi Z.A.; Ali S.M.; Ahmad S.; Ahmad S.A.; Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health 1999,4(4),284-287","journal-title":"Trop Med Int Health"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1440-0960.1992.tb00103.x","volume":"33","author":"Tong M.M.","year":"1992","unstructured":"Tong M.M.; Altman P.M.; Barnetson R.S.; Tea tree oil in the treatment of tinea pedis. Australas J Dermatol 1992,33(3),145-149","journal-title":"Australas J Dermatol"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1440-0960.2002.00590.x","volume":"43","author":"Satchell A.C.","year":"2002","unstructured":"Satchell A.C.; Saurajen A.; Bell C.; Barnetson R.S.; Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australas J Dermatol 2002,43(3),175-178","journal-title":"Australas J Dermatol"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1067\/mjd.2002.122734","volume":"47","author":"Satchell A.C.","year":"2002","unstructured":"Satchell A.C.; Saurajen A.; Bell C.; Barnetson R.S.; Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol 2002,47(6),852-855","journal-title":"J Am Acad Dermatol"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/CMR.19.1.50-62.2006","volume":"19","author":"Carson C.F.","year":"2006","unstructured":"Carson C.F.; Hammer K.A.; Riley T.V.; Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006,19(1),50-62","journal-title":"Clin Microbiol Rev"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/10412905.2013.860409","volume":"26","author":"Andrade B.F.M.T.","year":"2014","unstructured":"Andrade B.F.M.T.; Barbosa L.N.; Probst I.S.; Fernandes A.; Antimicrobial activity of essential oils. J Essent Oil Res 2014,26(1),34-40","journal-title":"J Essent Oil Res"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1472-765X.1994.tb00894.x","volume":"19","author":"Carson C.F.","year":"1994","unstructured":"Carson C.F.; Riley T.V.; Susceptibility of Propionibacterium acnes to the essential oil of Melaleuca alternifolia. Lett Appl Microbiol 1994,19(1),24-25","journal-title":"Lett Appl Microbiol"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2672.1995.tb05025.x","volume":"78","author":"Carson C.F.","year":"1995","unstructured":"Carson C.F.; Riley T.V.; Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J Appl Bacteriol 1995,78(3),264-269","journal-title":"J Appl Bacteriol"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/jac\/35.3.421","volume":"35","author":"Carson C.F.","year":"1995","unstructured":"Carson C.F.; Cookson B.D.; Farrelly H.D.; Riley T.V.; Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 1995,35(3),421-424","journal-title":"J Antimicrob Chemother"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1055\/s-2000-8604","volume":"66","author":"Christoph F.","year":"2000","unstructured":"Christoph F.; Kaulfers P.M.; Stahl-Biskup E.; A comparative study of the in vitro antimicrobial activity of tea tree oils s.l. with special reference to the activity of beta-triketones. Planta Med 2000,66(6),556-560","journal-title":"Planta Med"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0196-6553(96)90011-5","volume":"24","author":"Hammer K.A.","year":"1996","unstructured":"Hammer K.A.; Carson C.F.; Riley T.V.; Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 1996,24(3),186-189","journal-title":"Am J Infect Control"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1046\/j.1365-2672.1998.00379.x","volume":"84","author":"Mann C.M.","year":"1998","unstructured":"Mann C.M.; Markham J.L.; A new method for determining the minimum inhibitory concentration of essential oils. J Appl Microbiol 1998,84(4),538-544","journal-title":"J Appl Microbiol"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jac\/40.2.305","volume":"40","author":"Nelson R.R.","year":"1997","unstructured":"Nelson R.R.; In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1997,40(2),305-306","journal-title":"J Antimicrob Chemother"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1472-765X.1995.tb01051.x","volume":"21","author":"Raman A.","year":"1995","unstructured":"Raman A.; Weir U.; Bloomfield S.F.; Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Lett Appl Microbiol 1995,21(4),242-245","journal-title":"Lett Appl Microbiol"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/jac\/45.5.639","volume":"45","author":"May J.","year":"2000","unstructured":"May J.; Chan C.H.; King A.; Williams L.; French G.L.; Time-kill studies of tea tree oils on clinical isolates. J Antimicrob Chemother 2000,45(5),639-643","journal-title":"J Antimicrob Chemother"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/jac\/42.5.591","volume":"42","author":"Hammer K.A.","year":"1998","unstructured":"Hammer K.A.; Carson C.F.; Riley T.V.; In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 1998,42(5),591-595","journal-title":"J Antimicrob Chemother"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/10412905.2000.9699509","volume":"12","author":"Griffin S.G.","year":"2000","unstructured":"Griffin S.G.; Markham J.L.; Leach D.N.; An agar dilution method for the determination of the minimum inhibitory concentration of essential oils. J Essent Oil Res 2000,12(2),249-255","journal-title":"J Essent Oil Res"},{"key":"ref=254","first-page":"60","volume":"17","author":"Vazquez J.A.","year":"2000","unstructured":"Vazquez J.A.; Arganoza M.T.; Boikov D.; Akins R.A.; Vaishampayan J.K.; In vitro susceptibilities of Candida and Aspergillus species to Melaleuca alternafolia (tea tree) oil. Rev Iberoam Micol 2000,17(2),60-63","journal-title":"Rev Iberoam Micol"},{"key":"ref=255","first-page":"139","volume":"58","author":"Banes-Marshall L.","year":"2001","unstructured":"Banes-Marshall L.; Cawley P.; Phillips C.A.; In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Br J Biomed Sci 2001,58(3),139-145","journal-title":"Br J Biomed Sci"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1179\/joc.2001.13.4.377","volume":"13","author":"D\u2019Auria F.D.","year":"2001","unstructured":"D\u2019Auria F.D.; Laino L.; Strippoli V.; Tecca M.; Salvatore G.; Battinelli L.; Mazzanti G.; In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi. J Chemother 2001,13(4),377-383","journal-title":"J Chemother"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1179\/joc.2002.14.5.465","volume":"14","author":"Ergin A.","year":"2002","unstructured":"Ergin A.; Arikan S.; Comparison of microdilution and disc diffusion methods in assessing the in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates. J Chemother 2002,14(5),465-472","journal-title":"J Chemother"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/jac\/dkf112","volume":"50","author":"Hammer K.A.","year":"2002","unstructured":"Hammer K.A.; Carson C.F.; Riley T.V.; In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 2002,50(2),195-199","journal-title":"J Antimicrob Chemother"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1365-2672.2003.02059.x","volume":"95","author":"Hammer K.A.","year":"2003","unstructured":"Hammer K.A.; Carson C.F.; Riley T.V.; Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J Appl Microbiol 2003,95(4),853-860","journal-title":"J Appl Microbiol"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/jac\/dkg202","volume":"51","author":"Mondello F.","year":"2003","unstructured":"Mondello F.; De Bernardis F.; Girolamo A.; Salvatore G.; Cassone A.; In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 2003,51(5),1223-1229","journal-title":"J Antimicrob Chemother"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1472-765X.2003.01375.x","volume":"37","author":"Oliva B.","year":"2003","unstructured":"Oliva B.; Piccirilli E.; Ceddia T.; Pontieri E.; Aureli P.; Ferrini A.M.; Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Lett Appl Microbiol 2003,37(2),185-187","journal-title":"Lett Appl Microbiol"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1046\/j.1365-2672.2000.00943.x","volume":"88","author":"Cox S.D.","year":"2000","unstructured":"Cox S.D.; Mann C.M.; Markham J.L.; Bell H.C.; Gustafson J.E.; Warmington J.R.; Wyllie S.G.; The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol 2000,88(1),170-175","journal-title":"J Appl Microbiol"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/AAC.46.6.1914-1920.2002","volume":"46","author":"Carson C.F.","year":"2002","unstructured":"Carson C.F.; Mee B.J.; Riley T.V.; Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 2002,46(6),1914-1920","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1046\/j.1365-2672.2001.01406.x","volume":"91","author":"Cox S.D.","year":"2001","unstructured":"Cox S.D.; Mann C.M.; Markham J.L.; Interactions between components of the essential oil of Melaleuca alternifolia. J Appl Microbiol 2001,91(3),492-497","journal-title":"J Appl Microbiol"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1472-765X.2008.02334.x","volume":"46","author":"Loughlin R.","year":"2008","unstructured":"Loughlin R.; Gilmore B.F.; McCarron P.A.; Tunney M.M.; Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells. Lett Appl Microbiol 2008,46(4),428-433","journal-title":"Lett Appl Microbiol"},{"key":"ref=266","author":"Ramage G.","unstructured":"Ramage G.; Milligan S.; Lappin D.F.; Sherry L.; Sweeney P.; Williams C.; Bagg J.; Culshaw S.; Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients. Front Microbiol 3(220), 1-8.2012.","journal-title":"Front Microbiol"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/01.ju.0000152365.43125.3b","volume":"173","author":"Litwin M.S.","year":"2005","unstructured":"Litwin M.S.; Saigal C.S.; Yano E.M.; Avila C.; Geschwind S.A.; Hanley J.M.; Joyce G.F.; Madison R.; Pace J.; Polich S.M.; Wang M.; Urologic diseases in America Project: analytical methods and principal findings. J Urol 2005,173(3),933-937","journal-title":"J Urol"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1067\/mda.2003.7","volume":"49","author":"Foxman B.","year":"2003","unstructured":"Foxman B.; Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003,49(2),53-70","journal-title":"Dis Mon"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","volume":"113","author":"Foxman B.","year":"2002","unstructured":"Foxman B.; Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002,113(Suppl. 1A),5S-13S","journal-title":"Am J Med"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.ju.0000155596.98780.82","volume":"173","author":"Griebling T.L.","year":"2005","unstructured":"Griebling T.L.; Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol 2005,173(4),1281-1287","journal-title":"J Urol"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1067\/mda.2003.8","volume":"49","author":"Ronald A.","year":"2003","unstructured":"Ronald A.; The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003,49(2),71-82","journal-title":"Dis Mon"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jiph.2009.08.003","volume":"2","author":"Mittal R.","year":"2009","unstructured":"Mittal R.; Aggarwal S.; Sharma S.; Chhibber S.; Harjai K.; Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health 2009,2(3),101-111","journal-title":"J Infect Public Health"},{"key":"ref=273","first-page":"B4187","volume":"58","author":"Ejrn\u00e6s K.","year":"2011","unstructured":"Ejrn\u00e6s K.; Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan Med Bull 2011,58(4),B4187","journal-title":"Dan Med Bull"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.indcrop.2013.07.003","volume":"50","author":"Bazylko A.","year":"2013","unstructured":"Bazylko A.; Granica S.; Filipek A.; Piwowarski J.; Stefanska J.; Osinska E.; Kiss A.K.; Comparison of antioxidant, anti-inflammatory, antimicrobial activity and chemical composition of aqueous and hydroethanolic extracts of the herb of Tropaeolum majus L. Ind Crops Prod 2013,50,88-94","journal-title":"Ind Crops Prod"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/RRU.S133538","volume":"9","author":"Bonetta A.","year":"2017","unstructured":"Bonetta A.; Roviello G.; Generali D.; Zanotti L.; Cappelletti M.R.; Pacifico C.; Di Pierro F.; Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma. Res Rep Urol 2017,9,65-69","journal-title":"Res Rep Urol"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0094-0143(05)70212-3","volume":"26","author":"Wise G.J.","year":"1999","unstructured":"Wise G.J.; Talluri G.S.; Marella V.K.; Fungal infections of the genitourinary system: manifestations, diagnosis, and treatment. Urol Clin North Am [vii].1999,26(4),701-718","journal-title":"Urol Clin North Am"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ucl.2015.05.010","volume":"42","author":"Thomas L.","year":"2015","unstructured":"Thomas L.; Tracy C.R.; Treatment of fungal urinary tract infection. Urol Clin North Am 2015,42(4),473-483","journal-title":"Urol Clin North Am"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.lpm.2006.12.033","volume":"36","author":"Etienne M.","year":"2007","unstructured":"Etienne M.; Caron F.; Management of fungal urinary tract infections Presse Med 2007,36(12 Pt 3),1899-1906","journal-title":"Presse Med"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00345-013-1091-6","volume":"32","author":"Kranj\u010dec B.","year":"2014","unstructured":"Kranj\u010dec B.; Pape\u0161 D.; Altarac S.; D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 2014,32(1),79-84","journal-title":"World J Urol"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrurol.2015.199","volume":"12","author":"Zowawi H.M.","year":"2015","unstructured":"Zowawi H.M.; Harris P.N.A.; Roberts M.J.; Tambyah P.A.; Schembri M.A.; Pezzani M.D.; Williamson D.A.; Paterson D.L.; The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 2015,12(10),570-584","journal-title":"Nat Rev Urol"},{"key":"ref=281","first-page":"227","volume":"13","author":"Head K.A.","year":"2008","unstructured":"Head K.A.; Natural approaches to prevention and treatment of infections of the lower urinary tract. Altern Med Rev 2008,13(3),227-244","journal-title":"Altern Med Rev"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"c279","DOI":"10.1136\/bmj.c279","volume":"340","author":"Leydon G.M.","year":"2010","unstructured":"Leydon G.M.; Turner S.; Smith H.; Little P.; Team U.; Women\u2019s views about management and cause of urinary tract infection: qualitative interview study. BMJ 2010,340,c279","journal-title":"BMJ"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/pathogens5020036","volume":"5","author":"Beerepoot M.","year":"2016","unstructured":"Beerepoot M.; Geerlings S.; Non-antibiotic prophylaxis for urinary tract infections. Pathogens 2016,5(2),8","journal-title":"Pathogens"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5301\/uro.5000186","volume":"83","author":"Peri L.","year":"2016","unstructured":"Peri L.; Fighting urinary tract infections with antibiotic and non-antibiotic therapies. Urologia 2016,83(Suppl. 1),5-10","journal-title":"Urologia"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1086\/386328","volume":"38","author":"Raz R.","year":"2004","unstructured":"Raz R.; Chazan B.; Dan M.; Cranberry juice and urinary tract infection. Clin Infect Dis 2004,38(10),1413-1419","journal-title":"Clin Infect Dis"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"577","DOI":"10.9755\/ejfa.v26i7.16404","volume":"26","author":"Abreu O.A.","year":"2014","unstructured":"Abreu O.A.; Barreto G.; Prieto S.; Vaccinium (Ericaceae): Ethnobotany and pharmacological potentials. Emir J Food Agric 2014,26(7),577-591","journal-title":"Emir J Food Agric"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0022-5347(17)50751-X","volume":"131","author":"Sobota A.E.","year":"1984","unstructured":"Sobota A.E.; Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984,131(5),1013-1016","journal-title":"J Urol"},{"key":"ref=288","first-page":"173","volume":"55","author":"Schmidt D.R.","year":"1988","unstructured":"Schmidt D.R.; Sobota A.E.; An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 1988,55(224-225),173-181","journal-title":"Microbios"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1128\/AAC.33.1.92","volume":"33","author":"Zafriri D.","year":"1989","unstructured":"Zafriri D.; Ofek I.; Adar R.; Pocino M.; Sharon N.; Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989,33(1),92-98","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJM199105303242214","volume":"324","author":"Ofek I.","year":"1991","unstructured":"Ofek I.; Goldhar J.; Zafriri D.; Lis H.; Adar R.; Sharon N.; Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med 1991,324(22),1599-1599","journal-title":"N Engl J Med"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1574-695X.2000.tb01537.x","volume":"29","author":"Burger O.","year":"2000","unstructured":"Burger O.; Ofek I.; Tabak M.; Weiss E.I.; Sharon N.; Neeman I.; A high molecular mass constituent of cranberry juice inhibits helicobacter pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol 2000,29(4),295-301","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/jmf.2005.8.36","volume":"8","author":"Leit\u00e3o D.P.S.","year":"2005","unstructured":"Leit\u00e3o D.P.S.; Polizello A.C.M.; Ito I.Y.; Spadaro A.C.C.; Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice. J Med Food 2005,8(1),36-40","journal-title":"J Med Food"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.foodcont.2011.02.024","volume":"22","author":"Cote J.","year":"2011","unstructured":"Cote J.; Caillet S.; Doyon G.; Dussault D.; Sylvain J.F.; Lacroix M.; Antimicrobial effect of cranberry juice and extracts. Food Control 2011,22(8),1413-1418","journal-title":"Food Control"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.foodcont.2011.08.010","volume":"23","author":"Caillet S.","year":"2012","unstructured":"Caillet S.; Cote J.; Sylvain J.F.; Lacroix M.; Antimicrobial effects of fractions from cranberry products on the growth of seven pathogenic bacteria. Food Control 2012,23(2),419-428","journal-title":"Food Control"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1016\/j.foodres.2011.06.049","volume":"44","author":"Cote J.","year":"2011","unstructured":"Cote J.; Caillet S.; Dussault D.; Sylvain J.F.; Lacroix M.; Effect of juice processing on cranberry antibacterial properties. Food Res Int 2011,44(9),2922-2929","journal-title":"Food Res Int"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10068-011-0181-8","volume":"20","author":"Pinzon-Arango P.A.","year":"2011","unstructured":"Pinzon-Arango P.A.; Holguin K.; Camesano T.A.; Impact of cranberry juice and proanthocyanidins on the ability of Escherichia coli to form biofilms. Food Sci Biotechnol 2011,20(5),1315-1321","journal-title":"Food Sci Biotechnol"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jff.2015.05.016","volume":"17","author":"Sun J.","year":"2015","unstructured":"Sun J.; Marais J.P.J.; Khoo C.; LaPlante K.; Vejborg R.M.; Givskov M.; Tolker-Nielsen T.; Seeram N.P.; Rowley D.C.; Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic Escherichia coli. J Funct Foods 2015,17,235-242","journal-title":"J Funct Foods"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.juro.2017.03.078","volume":"198","author":"Lu\u00eds \u00c2.","year":"2017","unstructured":"Lu\u00eds \u00c2.; Domingues F.; Pereira L.; Can cranberries contribute to reduce the incidence of urinary tract infections? A systematic review with meta-analysis and trial sequential analysis of clinical trials. J Urol 2017,198(3),614-621","journal-title":"J Urol"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1590\/1516-3180.20131315T1","volume":"131","author":"Freire G.","year":"2013","unstructured":"Freire G.; C.; Williams, G.; Craig, J.C. Cranberries for preventing urinary tract infections. Sao Paulo Med J 2013,131(5),363-363","journal-title":"Sao Paulo Med J"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1021\/jf204912u","volume":"60","author":"S\u00e1nchez-Pat\u00e1n F.","year":"2012","unstructured":"S\u00e1nchez-Pat\u00e1n F.; Bartolom\u00e9 B.; Mart\u00edn-Alvarez P.J.; Anderson M.; Howell A.; Monagas M.; Comprehensive assessment of the quality of commercial cranberry products. Phenolic characterization and in vitro bioactivity. J Agric Food Chem 2012,60(13),3396-3408","journal-title":"J Agric Food Chem"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2327-5162.1000107","volume":"2","author":"Di Pierro F.","year":"2013","unstructured":"Di Pierro F.; The need for a more exact analytical characterization and dosing of cranberry extract in relation with its actual therapeutic properties. Altern Integr Med 2013,2(107),1-5","journal-title":"Altern Integr Med"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1021\/jf903710y","volume":"58","author":"Palikova I.","year":"2010","unstructured":"Palikova I.; Vostalova J.; Zdarilova A.; Svobodova A.; Kosina P.; Vecera R.; Stejskal D.; Proskova J.; Hrbac J.; Bednar P.; Maier V.; Cernochova D.; Simanek V.; Ulrichova J.; Long-term effects of three commercial cranberry products on the antioxidative status in rats: a pilot study. J Agric Food Chem 2010,58(3),1672-1678","journal-title":"J Agric Food Chem"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"H176","DOI":"10.1111\/j.1750-3841.2012.02788.x","volume":"77","author":"Grace M.H.","year":"2012","unstructured":"Grace M.H.; Massey A.R.; Mbeunkui F.; Yousef G.G.; Lila M.A.; Comparison of health-relevant flavonoids in commonly consumed cranberry products. J Food Sci 2012,77(8),H176-H183","journal-title":"J Food Sci"},{"key":"ref=304","first-page":"389","volume":"21","author":"Ledda A.","year":"2017","unstructured":"Ledda A.; Belcaro G.; Dugall M.; Riva A.; Togni S.; Eggenhoffner R.; Giacomelli L.; Highly standardized cranberry extract supplementation (Anthocran) as prophylaxis in young healthy subjects with recurrent urinary tract infections. Eur Rev Med Pharmacol Sci 2017,21(2),389-393","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=305","first-page":"77","volume":"19","author":"Ledda A.","year":"2015","unstructured":"Ledda A.; Bottari A.; Luzzi R.; Belcaro G.; Hu S.; Dugall M.; Hosoi M.; Ippolito E.; Corsi M.; Gizzi G.; Morazzoni P.; Riva A.; Giacomelli L.; Togni S.; Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study. Eur Rev Med Pharmacol Sci 2015,19(1),77-80","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=306","first-page":"5205","volume":"20","author":"Ledda A.","year":"2016","unstructured":"Ledda A.; Belcaro G.; Dugall M.; Feragalli B.; Riva A.; Togni S.; Giacomelli L.; Supplementation with high titer cranberry extract (Anthocran\u00ae) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study. Eur Rev Med Pharmacol Sci 2016,20(24),5205-5209","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2490-13-28","volume":"13","author":"S\u00e1nchez Ballester F.","year":"2013","unstructured":"S\u00e1nchez Ballester F.; Ruiz Vidal V.; L\u00f3pez Alcina E.; Domenech Perez C.; Escudero Fontano E.; Oltra Benavent A.; Montoliu Garc\u00eda A.; Sobr\u00f3n Bustamante M.; Cysticlean a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study. BMC Urol 2013,13,28","journal-title":"BMC Urol"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"14948","DOI":"10.3390\/molecules190914948","volume":"19","author":"B\u00e1rt\u00edkov\u00e1 H.","year":"2014","unstructured":"B\u00e1rt\u00edkov\u00e1 H.; Bou\u0161ov\u00e1 I.; Jedli\u010dkov\u00e1 P.; Ln\u011bni\u010dkov\u00e1 K.; Sk\u00e1lov\u00e1 L.; Szot\u00e1kov\u00e1 B.; Effect of standardized cranberry extract on the activity and expression of selected biotransformation enzymes in rat liver and intestine. Molecules 2014,19(9),14948-14960","journal-title":"Molecules"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1472-6882-13-90","volume":"13","author":"Diarra M.S.","year":"2013","unstructured":"Diarra M.S.; Block G.; Rempel H.; Oomah B.D.; Harrison J.; McCallum J.; Boulanger S.; Brouillette \u00c9.; Gattuso M.; Malouin F.; In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with \u03b2-lactams against Staphylococcus aureus. BMC Complement Altern Med 2013,13,90","journal-title":"BMC Complement Altern Med"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0011-393X(05)80204-8","volume":"53","author":"Larsson B.","year":"1993","unstructured":"Larsson B.; Jonasson A.; Fianu S.; Prophylactic effect of Uva-E in women with recurrent cystitis - a preliminary report. Curr Ther Res Clin Exp 1993,53(4),441-443","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1091581813507721","volume":"32","author":"de Arriba S.G.","year":"2013","unstructured":"de Arriba S.G.; Naser B.; Nolte K.U.; Risk assessment of free hydroquinone derived from Arctostaphylos Uva-ursi folium herbal preparations. Int J Toxicol 2013,32(6),442-453","journal-title":"Int J Toxicol"},{"key":"ref=312","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00345-002-0293-0","volume":"20","author":"Yarnell E.","year":"2002","unstructured":"Yarnell E.; Botanical medicines for the urinary tract. World J Urol 2002,20(5),285-293","journal-title":"World J Urol"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.hermed.2017.03.006","volume":"8","author":"Jurica K.","year":"2017","unstructured":"Jurica K.; Gobin I.; Kremer D.; Cepo D.V.; Grubesic R.J.; Karaconji I.B.; Kosalec I.; Arbutin and its metabolite hydroquinone as the main factors in the antimicrobial effect of strawberry tree (Arbutus unedo L.) leaves. J Herb Med 2017,8,17-23","journal-title":"J Herb Med"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1185\/030079907X233089","volume":"23","author":"Albrecht U.","year":"2007","unstructured":"Albrecht U.; Goos K.H.; Schneider B.; A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr Med Res Opin 2007,23(10),2415-2422","journal-title":"Curr Med Res Opin"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.foodcont.2008.03.007","volume":"20","author":"Nedorostova L.","year":"2009","unstructured":"Nedorostova L.; Kloucek P.; Kokoska L.; Stolcova M.; Pulkrabek J.; Antimicrobial properties of selected essential oils in vapour phase against foodborne bacteria. Food Control 2009,20(2),157-160","journal-title":"Food Control"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fcimb.2012.00053","volume":"2","author":"Dufour V.","year":"2012","unstructured":"Dufour V.; Alazzam B.; Ermel G.; Thepaut M.; Rossero A.; Tresse O.; Baysse C.; Antimicrobial activities of isothiocyanates against Campylobacter jejuni isolates. Front Cell Infect Microbiol 2012,2,53","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.foodchem.2017.03.150","volume":"232","author":"Deki\u0107 M.S.","year":"2017","unstructured":"Deki\u0107 M.S.; Radulovi\u0107 N.S.; Stojanovi\u0107 N.M.; Randjelovi\u0107 P.J.; Stojanovi\u0107-Radi\u0107 Z.Z.; Najman S.; Stojanovi\u0107 S.; Spasmolytic, antimicrobial and cytotoxic activities of 5-phenylpentyl isothiocyanate, a new glucosinolate autolysis product from horseradish (Armoracia rusticana P. Gaertn., B. Mey.","journal-title":"Food Chem"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jep.2008.07.036","volume":"119","author":"Moolla A.","year":"2008","unstructured":"Moolla A.; Viljoen A.M.; \u2018Buchu\u2019 -Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol 2008,119(3),413-419","journal-title":"J Ethnopharmacol"},{"key":"ref=319","first-page":"641","volume":"5","author":"Tserennadmid R.","year":"2010","unstructured":"Tserennadmid R.; Tako M.; Galgoczy L.; Papp T.; Vagvolgyi C.; Gero L.; Krisch J.; Antibacterial effect of essential oils and interaction with food components. Cent Eur J Biol 2010,5(5),641-648","journal-title":"Cent Eur J Biol"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/(SICI)1099-1573(199811)12:7<494:AID-PTR340>3.0.CO;2-N","volume":"12","author":"Stanic G.","year":"1998","unstructured":"Stanic G.; Samarzija I.; Blazevic N.; Time-dependent diuretic response in rats treated with juniper berry preparations. Phytother Res 1998,12(7),494-497","journal-title":"Phytother Res"},{"key":"ref=321","author":"Tisserand R.","year":"2014","unstructured":"Tisserand R.; Young R.; Essential Oil Safety: A Guide for Health Care Professionals 2014","journal-title":"Essential Oil Safety: A Guide for Health Care Professionals"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0015-6264(64)80192-9","volume":"2","author":"Jenner P.M.","year":"1964","unstructured":"Jenner P.M.; Hagan E.C.; Taylor J.M.; Cook E.L.; Fitzhugh O.G.; Food flavourings and compounds of related structure I. Acute oral toxicity. Food Cosmet Toxicol 1964,2(C),327-343","journal-title":"Food Cosmet Toxicol"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1099800411412767","volume":"14","author":"Chung Y.C.","year":"2012","unstructured":"Chung Y.C.; Chen H.H.; Yeh M.L.; Vinegar for decreasing catheter-associated bacteriuria in long-term catheterized patients: a randomized controlled trial. Biol Res Nurs 2012,14(3),294-301","journal-title":"Biol Res Nurs"},{"key":"ref=324","doi-asserted-by":"publisher","DOI":"10.1890\/1540-9295(2003)001[0421:UECTDP]2.0.CO;2","author":"Coley P.D.","year":"2003","unstructured":"Coley P.D.; Heller M.V.; Aizprua R.; Arauz B.; Flores N.; Correa M.; Gupta M.; Solis P.N.; Ortega-Barria E.; Romero L.I.; Gomez B.; Ramos M.; Cubilla-Rios L.; Capson T.L.; Kursar T.A.; Using ecological criteria to design plant collection strategies for drug discovery. Front Ecol Environ 1(8), 421-428.2003","journal-title":"Front Ecol Environ"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jep.2010.03.034","volume":"129","author":"Maregesi S.M.","year":"2010","unstructured":"Maregesi S.M.; Hermans N.; Dhooghe L.; Cimanga K.; Ferreira D.; Pannecouque C.; Vanden Berghe D.A.; Cos P.; Maes L.; Vlietinck A.J.; Apers S.; Pieters L.; Phytochemical and biological investigations of Elaeodendron schlechteranum. J Ethnopharmacol 2010,129(3),319-326","journal-title":"J Ethnopharmacol"},{"key":"ref=326","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.fitote.2014.01.024","volume":"94","author":"Novy P.","year":"2014","unstructured":"Novy P.; Kloucek P.; Rondevaldova J.; Havlik J.; Kourimska L.; Kokoska L.; Thymoquinone vapor significantly affects the results of Staphylococcus aureus sensitivity tests using the standard broth microdilution method. Fitoterapia 2014,94,102-107","journal-title":"Fitoterapia"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.arabjc.2015.04.021","volume":"10","author":"Rondevaldova J.","year":"2017","unstructured":"Rondevaldova J.; Novy P.; Urban J.; Kokoska L.; Determination of anti-staphylococcal activity of thymoquinone in combinations with antibiotics by checkerboard method using EVA capmatTM as a vapor barrier. Arab J Chem 2017,10(4),566-572","journal-title":"Arab J Chem"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.fitote.2017.02.008","volume":"118","author":"Houdkova M.","year":"2017","unstructured":"Houdkova M.; Rondevaldova J.; Doskocil I.; Kokoska L.; Evaluation of antibacterial potential and toxicity of plant volatile compounds using new broth microdilution volatilization method and modified MTT assay. Fitoterapia 2017,118,56-62","journal-title":"Fitoterapia"},{"key":"ref=329","first-page":"277","volume":"40","author":"Ventola C.L.","year":"2015","unstructured":"Ventola C.L.; The antibiotic resistance crisis: part 1: causes and threats. P 2015,40(4),277-283","journal-title":"P"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00253-012-4117-x","volume":"95","author":"Gyawali R.","year":"2012","unstructured":"Gyawali R.; Ibrahim S.A.; Impact of plant derivatives on the growth of foodborne pathogens and the functionality of probiotics. Appl Microbiol Biotechnol 2012,95(1),29-45","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=331","first-page":"173","volume":"15","author":"Drusch S.","year":"2010","unstructured":"Drusch S.; Microencapsulation of plant ingredients. Z Arznei Gewurzpflanzen 2010,15(4),173-178","journal-title":"Z Arznei Gewurzpflanzen"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jbiotec.2011.07.001","volume":"159","author":"Dons\u00ec F.","year":"2012","unstructured":"Dons\u00ec F.; Annunziata M.; Vincensi M.; Ferrari G.; Design of nanoemulsion-based delivery systems of natural antimicrobials: effect of the emulsifier. J Biotechnol 2012,159(4),342-350","journal-title":"J Biotechnol"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1128\/IAI.73.6.3197-3209.2005","volume":"73","author":"Kaper J.B.","year":"2005","unstructured":"Kaper J.B.; Sperandio V.; Bacterial cell-to-cell signaling in the gastrointestinal tract. Infect Immun 2005,73(6),3197-3209","journal-title":"Infect Immun"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.fitote.2018.07.002","volume":"129","author":"Netopilova M.","year":"2018","unstructured":"Netopilova M.; Houdkova M.; Rondevaldova J.; Kmet V.; Kokoska L.; Evaluation of in vitro growth-inhibitory effect of carvacrol and thymol combination against Staphylococcus aureus in liquid and vapour phase using new broth volatilization chequerboard method. Fitoterapia 2018,129,185-190","journal-title":"Fitoterapia"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/0735-260291044269","volume":"21","author":"Hadacek F.","year":"2002","unstructured":"Hadacek F.; Secondary metabolites as plant traits: Current assessment and future perspectives. Crit Rev Plant Sci 2002,21(4),273-322","journal-title":"Crit Rev Plant Sci"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0167-7799(02)02080-2","volume":"20","author":"Raskin I.","year":"2002","unstructured":"Raskin I.; Ribnicky D.M.; Komarnytsky S.; Ilic N.; Poulev A.; Borisjuk N.; Brinker A.; Moreno D.A.; Ripoll C.; Yakoby N.; O\u2019Neal J.M.; Cornwell T.; Pastor I.; Fridlender B.; Plants and human health in the twenty-first century. Trends Biotechnol 2002,20(12),522-531","journal-title":"Trends Biotechnol"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1439-0507.2003.00951.x","volume":"47","author":"Martin K.W.","year":"2004","unstructured":"Martin K.W.; Ernst E.; Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses 2004,47(3-4),87-92","journal-title":"Mycoses"},{"key":"ref=338","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.030540597","volume":"97","author":"Stermitz F.R.","year":"2000","unstructured":"Stermitz F.R.; Lorenz P.; Tawara J.N.; Zenewicz L.A.; Lewis K.; Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5\u2032-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 2000,97(4),1433-1437","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","volume":"761","author":"Kumar A.","year":"2015","unstructured":"Kumar A.; Ekavali; Chopra, K.; Mukherjee, M.; Pottabathini, R.; Dhull, D.K. Current knowledge and pharmacological profile of berberine: An update. Eur J Pharmacol 2015,761,288-297","journal-title":"Eur J Pharmacol"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.phymed.2008.06.008","volume":"15","author":"Hemaiswarya S.","year":"2008","unstructured":"Hemaiswarya S.; Kruthiventi A.K.; Doble M.; Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008,15(8),639-652","journal-title":"Phytomedicine"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/1040841X.2013.763219","volume":"40","author":"Langeveld W.T.","year":"2014","unstructured":"Langeveld W.T.; Veldhuizen E.J.A.; Burt S.A.; Synergy between essential oil components and antibiotics: a review. Crit Rev Microbiol 2014,40(1),76-94","journal-title":"Crit Rev Microbiol"},{"key":"ref=342","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1128\/AAC.38.9.2187","volume":"38","author":"Rambout L.","year":"1994","unstructured":"Rambout L.; Sahai J.; Gallicano K.; Oliveras L.; Garber G.; Effect of bismuth subsalicylate on ciprofloxacin bioavailability. Antimicrob Agents Chemother 1994,38(9),2187-2190","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1128\/AAC.49.1.431-433.2005","volume":"49","author":"Mahony D.E.","year":"2005","unstructured":"Mahony D.E.; Woods A.; Eelman M.D.; Burford N.; Veldhuyzen van Zanten S.J.O.; Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile. Antimicrob Agents Chemother 2005,49(1),431-433","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2174\/157340608784325098","volume":"4","author":"Oda Y.","year":"2008","unstructured":"Oda Y.; Kobayashi N.; Yamanoi T.; Katsuraya K.; Takahashi K.; Hattori K.; \u03b2-cyclodextrin conjugates with glucose moieties designed as drug carriers: their syntheses, evaluations using concanavalin A and doxorubicin, and structural analyses by NMR spectroscopy. Med Chem 2008,4(3),244-255","journal-title":"Med Chem"},{"key":"ref=345","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1139\/Y07-106","volume":"85","author":"Chauhan B.","year":"2007","unstructured":"Chauhan B.; Yu C.; Krantis A.; Scott I.; Arnason J.T.; Marles R.J.; Foster B.C.; In vitro activity of uva-ursi against cytochrome P450 isoenzymes and P-glycoprotein. Can J Physiol Pharmacol 2007,85(11),1099-1107","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T22:05:34Z","timestamp":1661983534000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165039\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,26]]},"references-count":345,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2019,10,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180831144344","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}